| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.672 | 0.004 | 0.672 | EphB2 antagonist | 0.285 0.041 DBMET00780 0.599 0.005 DBMET01162 | ||
| 0.539 | 0.027 | 0.588 | Aldehyde oxidase inhibitor | 0.344 0.056 DBMET00780 0.588 0.021 DBMET01162 | DBMET01162 | |
| 0.506 | 0.024 | 0.506 | GABA C receptor rho-3 antagonist | 0.4 0.062 DBMET00780 0.231 0.172 DBMET01161 0.413 0.056 DBMET01162 | ||
| 0.483 | 0.005 | 0.483 | Bronchodilator | 0.259 0.012 DBMET00780 0.101 0.063 DBMET01162 | ||
| 0.465 | 0.004 | 0.734 | DNA polymerase I inhibitor | 0.572 0.003 DBMET00657 0.227 0.021 DBMET00780 0.256 0.016 DBMET01162 0.547 0.003 DBMET01151 0.61 0.002 DBMET01158 0.432 0.005 DBMET01159 0.604 0.002 DBMET01152 0.523 0.004 DBMET01160 0.586 0.003 DBMET01153 0.696 0.001 DBMET01154 0.724 0.001 DBMET01155 0.707 0.001 DBMET01156 0.734 0.001 DBMET01157 | DBMET01157 | |
| 0.451 | 0.034 | 0.451 | MAP kinase kinase 6 inhibitor | 0.279 0.157 DBMET00780 | ||
| 0.419 | 0.006 | 0.419 | c-Src kinase inhibitor | 0.142 0.059 DBMET00780 0.372 0.009 DBMET01162 0.114 0.08 DBMET01158 | ||
| 0.413 | 0.005 | 0.413 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.124 0.038 DBMET00780 0.22 0.015 DBMET01162 | ||
| 0.412 | 0.024 | 0.412 | Interleukin 2 agonist | 0.374 0.036 DBMET00780 0.267 0.1 DBMET01159 0.319 0.061 DBMET01152 0.265 0.103 DBMET01160 0.295 0.077 DBMET01154 0.287 0.083 DBMET01155 0.271 0.097 DBMET01156 0.263 0.105 DBMET01157 | ||
| 0.374 | 0.005 | 0.374 | Raf kinase B inhibitor | 0.089 0.025 DBMET00780 0.167 0.012 DBMET01162 | ||
| 0.367 | 0.005 | 0.367 | Raf kinase inhibitor | 0.104 0.03 DBMET00780 0.17 0.016 DBMET01162 | ||
| 0.362 | 0.01 | 0.362 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.245 0.072 DBMET00780 0.221 0.113 DBMET01162 0.21 0.14 DBMET01159 0.209 0.14 DBMET01160 | ||
| 0.422 | 0.082 | 0.422 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.291 0.226 DBMET00780 0.396 0.104 DBMET01162 | ||
| 0.36 | 0.028 | 0.992 | DNA synthesis inhibitor | 0.861 0.002 DBMET00657 0.274 0.054 DBMET00780 0.198 0.126 DBMET01161 0.372 0.026 DBMET01162 0.782 0.003 DBMET01151 0.848 0.003 DBMET01158 0.696 0.005 DBMET01159 0.973 0.001 DBMET01152 0.673 0.005 DBMET01160 0.938 0.001 DBMET01153 0.988 0.001 DBMET01154 0.991 0 DBMET01155 0.989 0.001 DBMET01156 0.992 0 DBMET01157 | DBMET01157 | |
| 0.342 | 0.01 | 0.342 | Glycogen synthase kinase-3 beta inhibitor | 0.177 0.034 DBMET00780 | ||
| 0.34 | 0.012 | 0.34 | Glycogen synthase kinase-3 inhibitor | 0.16 0.042 DBMET00780 | ||
| 0.347 | 0.024 | 0.987 | RNA-directed DNA polymerase inhibitor | 0.864 0.001 DBMET00657 0.32 0.028 DBMET00780 0.217 0.077 DBMET01161 0.354 0.023 DBMET01162 0.755 0.002 DBMET01151 0.797 0.002 DBMET01158 0.69 0.003 DBMET01159 0.947 0.001 DBMET01152 0.651 0.003 DBMET01160 0.91 0.001 DBMET01153 0.977 0 DBMET01154 0.983 0 DBMET01155 0.983 0 DBMET01156 0.987 0 DBMET01157 | DBMET01157 | |
| 0.325 | 0.004 | 0.325 | 5 Hydroxytryptamine 3E antagonist | 0.203 0.058 DBMET00780 0.321 0.004 DBMET01162 | ||
| 0.323 | 0.005 | 0.323 | Phosphatidylinositol 3-kinase delta inhibitor | 0.065 0.033 DBMET00780 0.291 0.005 DBMET01162 | ||
| 0.316 | 0.007 | 0.502 | Xanthine oxidase inhibitor | 0.502 0.004 DBMET00780 0.366 0.005 DBMET01161 0.195 0.02 DBMET01162 0.086 0.079 DBMET01151 0.165 0.029 DBMET01159 0.094 0.066 DBMET01160 | DBMET00780 | |
| 0.322 | 0.022 | 0.322 | Src kinase inhibitor | 0.312 0.024 DBMET01162 | ||
| 0.295 | 0.007 | 0.833 | NADH dehydrogenase inhibitor | 0.833 0 DBMET00657 0.282 0.007 DBMET00780 0.126 0.026 DBMET01161 0.258 0.008 DBMET01162 0.796 0.001 DBMET01151 0.821 0 DBMET01158 0.729 0.001 DBMET01159 0.762 0.001 DBMET01152 0.71 0.001 DBMET01160 0.729 0.001 DBMET01153 0.806 0.001 DBMET01154 0.792 0.001 DBMET01155 0.786 0.001 DBMET01156 0.771 0.001 DBMET01157 | DBMET00657 | |
| 0.29 | 0.01 | 0.29 | GABA C receptor agonist | 0.249 0.014 DBMET00780 0.12 0.05 DBMET01161 0.254 0.013 DBMET01162 | ||
| 0.281 | 0.005 | 0.281 | Phosphodiesterase 7B inhibitor | 0.207 0.009 DBMET00780 0.104 0.052 DBMET01162 | ||
| 0.276 | 0.005 | 0.276 | MAP kinase 3 inhibitor | 0.181 0.034 DBMET00780 0.201 0.023 DBMET01162 0.209 0.02 DBMET01152 0.137 0.091 DBMET01160 0.145 0.076 DBMET01154 0.133 0.099 DBMET01155 | ||
| 0.281 | 0.03 | 0.973 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.973 0 DBMET00657 0.246 0.044 DBMET00780 0.307 0.021 DBMET01161 0.197 0.075 DBMET01162 0.875 0 DBMET01151 0.85 0 DBMET01158 0.881 0 DBMET01159 0.695 0.001 DBMET01152 0.724 0.001 DBMET01160 0.645 0.002 DBMET01153 0.757 0.001 DBMET01154 0.728 0.001 DBMET01155 0.671 0.001 DBMET01156 0.66 0.001 DBMET01157 | DBMET00657 | |
| 0.239 | 0.009 | 0.74 | Adenosine A1 receptor antagonist | 0.347 0.005 DBMET00657 0.195 0.011 DBMET00780 0.073 0.031 DBMET01161 0.127 0.019 DBMET01162 0.298 0.006 DBMET01151 0.395 0.004 DBMET01158 0.689 0.002 DBMET01159 0.502 0.003 DBMET01152 0.74 0.002 DBMET01160 0.308 0.006 DBMET01153 0.328 0.005 DBMET01154 0.288 0.007 DBMET01155 0.223 0.009 DBMET01156 0.192 0.012 DBMET01157 | DBMET01160 | |
| 0.245 | 0.018 | 0.249 | Cyclin-dependent kinase 1 inhibitor | 0.249 0.018 DBMET01162 | DBMET01162 | |
| 0.227 | 0.006 | 0.257 | CDK1/cyclin B1 inhibitor | 0.099 0.029 DBMET00780 0.257 0.005 DBMET01162 | DBMET01162 | |
| 0.224 | 0.028 | 0.241 | Ribosomal protein S6 kinase inhibitor | 0.241 0.023 DBMET01162 | DBMET01162 | |
| 0.316 | 0.121 | 0.477 | 15-Lipoxygenase inhibitor | 0.327 0.113 DBMET00780 0.477 0.046 DBMET01161 | DBMET01161 | |
| 0.253 | 0.059 | 0.253 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.155 0.138 DBMET01160 | ||
| 0.201 | 0.01 | 0.564 | Adenosine A2 receptor antagonist | 0.175 0.013 DBMET00657 0.123 0.021 DBMET00780 0.114 0.023 DBMET01162 0.129 0.02 DBMET01151 0.197 0.011 DBMET01158 0.517 0.003 DBMET01159 0.311 0.005 DBMET01152 0.564 0.003 DBMET01160 0.152 0.016 DBMET01153 0.215 0.009 DBMET01154 0.182 0.012 DBMET01155 0.07 0.04 DBMET01156 | DBMET01160 | |
| 0.249 | 0.064 | 0.612 | Cyclic AMP phosphodiesterase inhibitor | 0.403 0.016 DBMET00657 0.179 0.112 DBMET00780 0.302 0.041 DBMET01162 0.311 0.038 DBMET01151 0.41 0.015 DBMET01158 0.605 0.004 DBMET01159 0.184 0.107 DBMET01152 0.612 0.004 DBMET01160 0.191 0.101 DBMET01153 | DBMET01160 | |
| 0.219 | 0.039 | 0.219 | Protein-tyrosine kinase Lyn inhibitor | 0.111 0.092 DBMET00780 0.169 0.057 DBMET01162 | ||
| 0.295 | 0.118 | 0.602 | Immunosuppressant | 0.602 0.013 DBMET00657 0.344 0.09 DBMET01162 0.551 0.02 DBMET01151 0.566 0.018 DBMET01158 0.526 0.026 DBMET01159 0.574 0.017 DBMET01152 0.477 0.039 DBMET01160 0.565 0.018 DBMET01153 0.521 0.028 DBMET01154 0.513 0.029 DBMET01155 0.52 0.028 DBMET01156 0.513 0.03 DBMET01157 | DBMET00657 | |
| 0.187 | 0.014 | 0.718 | Alcohol dehydrogenase inhibitor | 0.718 0.001 DBMET00657 0.131 0.028 DBMET00780 0.12 0.035 DBMET01161 0.642 0.002 DBMET01151 0.427 0.004 DBMET01158 0.596 0.002 DBMET01159 0.591 0.002 DBMET01152 0.215 0.011 DBMET01160 0.21 0.011 DBMET01153 0.621 0.002 DBMET01154 0.592 0.002 DBMET01155 0.425 0.004 DBMET01156 0.372 0.004 DBMET01157 | DBMET00657 | |
| 0.184 | 0.011 | 0.513 | Adenosine A2a receptor antagonist | 0.133 0.018 DBMET00657 0.113 0.022 DBMET00780 0.113 0.022 DBMET01162 0.098 0.025 DBMET01151 0.158 0.014 DBMET01158 0.465 0.003 DBMET01159 0.171 0.013 DBMET01152 0.513 0.003 DBMET01160 0.125 0.019 DBMET01153 0.117 0.021 DBMET01154 0.09 0.028 DBMET01155 | DBMET01160 | |
| 0.223 | 0.052 | 0.223 | LIM domain kinase 1 inhibitor | 0.217 0.055 DBMET01162 | ||
| 0.178 | 0.01 | 0.887 | Antimetabolite | 0.829 0.001 DBMET00657 0.129 0.013 DBMET00780 0.135 0.013 DBMET01161 0.08 0.019 DBMET01162 0.771 0.001 DBMET01151 0.772 0.001 DBMET01158 0.57 0.002 DBMET01159 0.804 0.001 DBMET01152 0.494 0.003 DBMET01160 0.518 0.002 DBMET01153 0.879 0.001 DBMET01154 0.886 0.001 DBMET01155 0.88 0.001 DBMET01156 0.887 0.001 DBMET01157 | DBMET01157 | |
| 0.201 | 0.034 | 0.201 | Cyclooxygenase 1 inhibitor | 0.163 0.05 DBMET00780 | ||
| 0.164 | 0.005 | 0.218 | Cyclin B1 inhibitor | 0.218 0.004 DBMET01162 | DBMET01162 | |
| 0.164 | 0.006 | 0.164 | Alpha 2d adrenoreceptor antagonist | 0.135 0.014 DBMET00780 0.155 0.008 DBMET01162 | ||
| 0.189 | 0.036 | 0.189 | GABA C receptor rho-2 antagonist | 0.139 0.09 DBMET00780 0.149 0.075 DBMET01162 | ||
| 0.155 | 0.005 | 0.191 | Cyclin B2 inhibitor | 0.191 0.004 DBMET01162 | DBMET01162 | |
| 0.158 | 0.012 | 0.612 | Adenosine A3 receptor antagonist | 0.19 0.01 DBMET00657 0.133 0.015 DBMET00780 0.078 0.047 DBMET01161 0.202 0.009 DBMET01162 0.136 0.014 DBMET01151 0.295 0.005 DBMET01158 0.537 0.003 DBMET01159 0.162 0.011 DBMET01152 0.612 0.002 DBMET01160 0.152 0.012 DBMET01153 0.153 0.012 DBMET01154 0.153 0.012 DBMET01155 0.089 0.033 DBMET01156 0.089 0.033 DBMET01157 | DBMET01160 | |
| 0.193 | 0.049 | 0.193 | Polo-like kinase-3 inhibitor | 0.146 0.089 DBMET00780 | ||
| 0.244 | 0.102 | 0.276 | Insulysin inhibitor | 0.198 0.159 DBMET00780 0.19 0.173 DBMET01161 0.276 0.074 DBMET01162 | DBMET01162 | |
| 0.146 | 0.005 | 0.182 | Cyclin B inhibitor | 0.182 0.005 DBMET01162 | DBMET01162 | |
| 0.158 | 0.018 | 0.158 | GABA C receptor rho-1 antagonist | 0.113 0.047 DBMET00780 0.12 0.04 DBMET01162 | ||
| 0.244 | 0.106 | 0.607 | Hypoxia-inducible factor 1 alpha inhibitor | 0.238 0.112 DBMET00657 0.22 0.13 DBMET00780 0.186 0.171 DBMET01162 0.321 0.056 DBMET01158 0.49 0.016 DBMET01159 0.607 0.007 DBMET01160 | DBMET01160 | |
| 0.157 | 0.027 | 0.157 | GABA C receptor antagonist | 0.122 0.051 DBMET00780 0.121 0.051 DBMET01162 | ||
| 0.206 | 0.079 | 0.206 | Nitric-oxide synthase stimulant | 0.172 0.148 DBMET00780 0.202 0.086 DBMET01162 | ||
| 0.198 | 0.073 | 0.198 | I kappa B kinase epsilon inhibitor | 0.194 0.076 DBMET01162 | ||
| 0.134 | 0.01 | 0.155 | Protein kinase B beta inhibitor | 0.085 0.037 DBMET00780 0.155 0.007 DBMET01162 | DBMET01162 | |
| 0.169 | 0.047 | 0.169 | Histone deacetylase SIRT1 inhibitor | 0.151 0.06 DBMET00780 | ||
| 0.148 | 0.027 | 0.639 | Adenylate kinase inhibitor | 0.639 0 DBMET00657 0.122 0.042 DBMET00780 0.112 0.051 DBMET01161 0.144 0.029 DBMET01162 0.594 0.001 DBMET01151 0.609 0 DBMET01158 0.515 0.001 DBMET01159 0.555 0.001 DBMET01152 0.478 0.002 DBMET01160 0.54 0.001 DBMET01153 0.589 0.001 DBMET01154 0.599 0 DBMET01155 0.503 0.001 DBMET01156 0.516 0.001 DBMET01157 | DBMET00657 | |
| 0.15 | 0.031 | 0.617 | DNA repair enzyme inhibitor | 0.468 0.003 DBMET00657 0.204 0.008 DBMET00780 0.154 0.028 DBMET01161 0.152 0.03 DBMET01162 0.5 0.002 DBMET01151 0.419 0.003 DBMET01158 0.358 0.004 DBMET01159 0.617 0.002 DBMET01152 0.311 0.004 DBMET01160 0.565 0.002 DBMET01153 0.404 0.003 DBMET01154 0.363 0.004 DBMET01155 0.419 0.003 DBMET01156 0.375 0.004 DBMET01157 | DBMET01152 | |
| 0.151 | 0.032 | 0.151 | Protein kinase (CK2) inhibitor | 0.116 0.05 DBMET00780 0.118 0.05 DBMET01162 | ||
| 0.121 | 0.004 | 0.465 | AICAR transformylase inhibitor | 0.29 0.001 DBMET00657 0.07 0.01 DBMET00780 0.064 0.012 DBMET01162 0.188 0.002 DBMET01151 0.29 0.001 DBMET01158 0.165 0.003 DBMET01159 0.465 0 DBMET01152 0.165 0.003 DBMET01160 0.278 0.001 DBMET01153 0.319 0.001 DBMET01154 0.297 0.001 DBMET01155 0.203 0.002 DBMET01156 0.19 0.002 DBMET01157 | DBMET01152 | |
| 0.145 | 0.028 | 0.172 | CDK2/cyclin A inhibitor | 0.172 0.02 DBMET01162 | DBMET01162 | |
| 0.179 | 0.066 | 0.182 | Peroxidase inhibitor | 0.182 0.065 DBMET00780 0.149 0.078 DBMET01161 | DBMET00780 | |
| 0.127 | 0.014 | 0.749 | Carbamoyl phosphate synthetase inhibitor | 0.749 0 DBMET00657 0.104 0.019 DBMET00780 0.056 0.047 DBMET01161 0.114 0.017 DBMET01162 0.692 0.001 DBMET01151 0.736 0 DBMET01158 0.583 0.001 DBMET01159 0.679 0.001 DBMET01152 0.562 0.002 DBMET01160 0.649 0.001 DBMET01153 0.72 0.001 DBMET01154 0.733 0 DBMET01155 0.628 0.001 DBMET01156 0.645 0.001 DBMET01157 | DBMET00657 | |
| 0.146 | 0.038 | 0.146 | Ephrin antagonist | 0.102 0.061 DBMET01162 | ||
| 0.123 | 0.016 | 0.123 | Phosphatidylinositol kinase inhibitor | 0.075 0.03 DBMET01162 | ||
| 0.19 | 0.083 | 0.227 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.227 0.054 DBMET01162 | DBMET01162 | |
| 0.19 | 0.085 | 0.19 | Histone acetyltransferase inhibitor | |||
| 0.142 | 0.039 | 0.142 | MAP kinase kinase kinase inhibitor | 0.117 0.052 DBMET01162 | ||
| 0.104 | 0.002 | 0.78 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.655 0 DBMET00657 0.074 0.005 DBMET00780 0.079 0.004 DBMET01161 0.077 0.005 DBMET01162 0.271 0 DBMET01151 0.265 0 DBMET01158 0.24 0 DBMET01159 0.457 0 DBMET01152 0.163 0.001 DBMET01160 0.246 0 DBMET01153 0.72 0 DBMET01154 0.78 0 DBMET01155 0.28 0 DBMET01156 0.301 0 DBMET01157 | DBMET01155 | |
| 0.158 | 0.057 | 0.158 | RET inhibitor | 0.139 0.067 DBMET01162 | ||
| 0.148 | 0.048 | 0.148 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.129 0.061 DBMET01162 | ||
| 0.148 | 0.048 | 0.148 | Abl kinase inhibitor | 0.128 0.061 DBMET01162 | ||
| 0.131 | 0.032 | 0.159 | Uric acid excretion stimulant | 0.13 0.032 DBMET00780 0.159 0.02 DBMET01161 0.082 0.08 DBMET01162 0.128 0.034 DBMET01159 0.124 0.036 DBMET01160 | DBMET01161 | |
| 0.121 | 0.025 | 0.153 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.153 0.013 DBMET01162 | DBMET01162 | |
| 0.101 | 0.006 | 0.101 | Histamine H3 receptor agonist | 0.073 0.008 DBMET01162 | ||
| 0.261 | 0.167 | 0.575 | Antibacterial | 0.505 0.039 DBMET00657 0.257 0.171 DBMET00780 0.289 0.143 DBMET01161 0.545 0.03 DBMET01151 0.467 0.051 DBMET01158 0.526 0.034 DBMET01159 0.575 0.023 DBMET01152 0.491 0.043 DBMET01160 0.454 0.055 DBMET01153 0.555 0.027 DBMET01154 0.527 0.033 DBMET01155 0.548 0.029 DBMET01156 0.518 0.036 DBMET01157 | DBMET01152 | |
| 0.104 | 0.01 | 0.104 | MAP kinase kinase 7 inhibitor | 0.086 0.031 DBMET00780 0.091 0.024 DBMET01162 | ||
| 0.144 | 0.051 | 0.144 | Antibacterial (Helicobacter pylori) | 0.135 0.062 DBMET01162 | ||
| 0.097 | 0.004 | 0.222 | Purinergic P2Y2 antagonist | 0.149 0.003 DBMET00657 0.073 0.006 DBMET00780 0.143 0.003 DBMET01151 0.148 0.003 DBMET01158 0.044 0.013 DBMET01159 0.175 0.002 DBMET01152 0.046 0.012 DBMET01160 0.13 0.003 DBMET01153 0.211 0.001 DBMET01154 0.222 0.001 DBMET01155 0.193 0.002 DBMET01156 0.203 0.002 DBMET01157 | DBMET01155 | |
| 0.104 | 0.013 | 0.824 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.794 0 DBMET00657 0.085 0.018 DBMET00780 0.072 0.024 DBMET01161 0.076 0.022 DBMET01162 0.701 0 DBMET01151 0.686 0 DBMET01158 0.62 0.001 DBMET01159 0.74 0 DBMET01152 0.503 0.001 DBMET01160 0.649 0.001 DBMET01153 0.805 0 DBMET01154 0.824 0 DBMET01155 0.771 0 DBMET01156 0.792 0 DBMET01157 | DBMET01155 | |
| 0.17 | 0.08 | 0.17 | Tyrosine kinase inhibitor | |||
| 0.101 | 0.013 | 0.143 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.085 0.028 DBMET00657 0.072 0.055 DBMET00780 0.087 0.026 DBMET01162 0.089 0.024 DBMET01158 0.137 0.004 DBMET01159 0.091 0.022 DBMET01152 0.143 0.004 DBMET01160 0.072 0.056 DBMET01153 0.073 0.051 DBMET01154 0.068 0.066 DBMET01155 | DBMET01160 | |
| 0.141 | 0.054 | 0.141 | Epidermal growth factor receptor kinase inhibitor | 0.112 0.081 DBMET01162 | ||
| 0.093 | 0.006 | 0.902 | Adenosine deaminase inhibitor | 0.571 0.001 DBMET00657 0.075 0.011 DBMET00780 0.092 0.007 DBMET01162 0.208 0.002 DBMET01151 0.838 0.001 DBMET01158 0.66 0.001 DBMET01159 0.533 0.001 DBMET01152 0.902 0.001 DBMET01160 0.438 0.001 DBMET01153 0.678 0.001 DBMET01154 0.599 0.001 DBMET01155 0.655 0.001 DBMET01156 0.573 0.001 DBMET01157 | DBMET01160 | |
| 0.089 | 0.004 | 0.139 | Alpha 1d adrenoreceptor agonist | 0.139 0.002 DBMET01162 | DBMET01162 | |
| 0.104 | 0.021 | 0.92 | Phosphodiesterase III inhibitor | 0.61 0.003 DBMET00780 0.92 0.001 DBMET01161 0.102 0.022 DBMET01162 0.135 0.012 DBMET01151 | DBMET01161 | |
| 0.224 | 0.142 | 0.612 | Prostaglandin dehydrogenase inhibitor | 0.308 0.098 DBMET00780 0.612 0.023 DBMET01161 | DBMET01161 | |
| 0.146 | 0.065 | 0.146 | MAP3K9 inhibitor | 0.139 0.078 DBMET01162 | ||
| 0.104 | 0.023 | 0.135 | CDK1/cyclin B inhibitor | 0.135 0.015 DBMET01162 | DBMET01162 | |
| 0.142 | 0.062 | 0.218 | Aurora-C kinase inhibitor | 0.218 0.015 DBMET01162 | DBMET01162 | |
| 0.086 | 0.007 | 0.171 | Alpha 1b adrenoreceptor agonist | 0.171 0.003 DBMET01162 | DBMET01162 | |
| 0.14 | 0.061 | 0.192 | Alpha-N-acetylglucosaminidase inhibitor | 0.123 0.075 DBMET00780 0.118 0.08 DBMET01161 0.123 0.075 DBMET01162 0.192 0.037 DBMET01159 0.169 0.045 DBMET01160 | DBMET01159 | |
| 0.085 | 0.008 | 0.928 | Thymidine kinase inhibitor | 0.56 0.001 DBMET00657 0.07 0.011 DBMET00780 0.038 0.033 DBMET01161 0.086 0.008 DBMET01162 0.39 0.002 DBMET01151 0.477 0.002 DBMET01158 0.209 0.003 DBMET01159 0.778 0.001 DBMET01152 0.178 0.003 DBMET01160 0.747 0.001 DBMET01153 0.876 0.001 DBMET01154 0.898 0.001 DBMET01155 0.906 0 DBMET01156 0.928 0 DBMET01157 | DBMET01157 | |
| 0.151 | 0.075 | 0.191 | CF transmembrane conductance regulator agonist | 0.191 0.027 DBMET01162 0.159 0.061 DBMET01160 | DBMET01162 | |
| 0.09 | 0.015 | 0.09 | Exportin-1 inhibitor | 0.076 0.031 DBMET01162 | ||
| 0.076 | 0.001 | 0.076 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.011 DBMET00657 0.037 0.002 DBMET00780 0.018 0.009 DBMET01161 0.066 0.001 DBMET01162 0.017 0.012 DBMET01158 0.024 0.004 DBMET01159 0.03 0.003 DBMET01152 0.023 0.004 DBMET01160 0.029 0.003 DBMET01153 0.028 0.003 DBMET01154 0.027 0.004 DBMET01155 0.03 0.003 DBMET01156 0.029 0.003 DBMET01157 | ||
| 0.125 | 0.051 | 0.125 | Ferrochelatase inhibitor | 0.105 0.065 DBMET01162 | ||
| 0.11 | 0.038 | 0.123 | Histamine N-methyltransferase inhibitor | 0.123 0.028 DBMET01162 0.095 0.051 DBMET01159 0.12 0.03 DBMET01160 | DBMET01162 | |
| 0.148 | 0.077 | 0.928 | Cytidine deaminase inhibitor | 0.858 0.002 DBMET00657 0.137 0.085 DBMET00780 0.44 0.008 DBMET01161 0.928 0.001 DBMET01151 0.569 0.004 DBMET01158 0.766 0.003 DBMET01159 0.641 0.004 DBMET01152 0.431 0.008 DBMET01160 0.535 0.005 DBMET01153 0.741 0.003 DBMET01154 0.771 0.002 DBMET01155 0.739 0.003 DBMET01156 0.769 0.002 DBMET01157 | DBMET01151 | |
| 0.119 | 0.049 | 0.119 | Multidrug resistance-associated protein 1 inhibitor | 0.094 0.089 DBMET01162 0.105 0.07 DBMET01160 | ||
| 0.089 | 0.021 | 0.095 | Alcohol oxidase inhibitor | 0.095 0.019 DBMET00780 0.052 0.043 DBMET01162 | DBMET00780 | |
| 0.098 | 0.031 | 0.098 | Protein kinase B alpha inhibitor | 0.074 0.045 DBMET01162 | ||
| 0.102 | 0.035 | 0.118 | Porphobilinogen synthase inhibitor | 0.077 0.05 DBMET00780 0.118 0.029 DBMET01162 | DBMET01162 | |
| 0.098 | 0.032 | 0.88 | Glutamate dehydrogenase inhibitor | 0.88 0.001 DBMET00657 0.077 0.048 DBMET00780 0.068 0.059 DBMET01161 0.085 0.04 DBMET01162 0.833 0.001 DBMET01151 0.832 0.001 DBMET01158 0.666 0.002 DBMET01159 0.833 0.001 DBMET01152 0.452 0.004 DBMET01160 0.796 0.001 DBMET01153 0.867 0.001 DBMET01154 0.876 0.001 DBMET01155 0.77 0.001 DBMET01156 0.791 0.001 DBMET01157 | DBMET00657 | |
| 0.175 | 0.109 | 0.175 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.142 0.138 DBMET00780 0.163 0.119 DBMET01162 | ||
| 0.193 | 0.127 | 0.503 | Interleukin agonist | 0.249 0.079 DBMET00657 0.189 0.131 DBMET01151 0.231 0.094 DBMET01158 0.327 0.036 DBMET01159 0.503 0.009 DBMET01152 0.309 0.044 DBMET01160 0.31 0.043 DBMET01153 0.403 0.018 DBMET01154 0.37 0.024 DBMET01155 0.264 0.069 DBMET01156 0.236 0.089 DBMET01157 | DBMET01152 | |
| 0.124 | 0.059 | 0.124 | Protein kinase (CK2) alpha inhibitor | 0.099 0.077 DBMET01162 | ||
| 0.086 | 0.023 | 0.622 | Biliverdin reductase inhibitor | 0.622 0.001 DBMET00657 0.08 0.026 DBMET00780 0.052 0.051 DBMET01161 0.074 0.029 DBMET01162 0.575 0.001 DBMET01151 0.602 0.001 DBMET01158 0.392 0.002 DBMET01159 0.526 0.001 DBMET01152 0.366 0.002 DBMET01160 0.484 0.001 DBMET01153 0.547 0.001 DBMET01154 0.526 0.001 DBMET01155 0.39 0.002 DBMET01156 0.365 0.002 DBMET01157 | DBMET00657 | |
| 0.07 | 0.008 | 0.07 | Dopamine beta hydroxylase inhibitor | 0.056 0.02 DBMET00780 0.055 0.022 DBMET01161 | ||
| 0.104 | 0.042 | 0.146 | Protein kinase A inhibitor | 0.146 0.025 DBMET01162 | DBMET01162 | |
| 0.085 | 0.023 | 0.843 | Argininosuccinate synthase inhibitor | 0.744 0.001 DBMET00657 0.062 0.035 DBMET00780 0.073 0.029 DBMET01162 0.606 0.001 DBMET01151 0.719 0.001 DBMET01158 0.356 0.003 DBMET01159 0.764 0.001 DBMET01152 0.331 0.003 DBMET01160 0.715 0.001 DBMET01153 0.825 0 DBMET01154 0.843 0 DBMET01155 0.824 0 DBMET01156 0.842 0 DBMET01157 | DBMET01155 | |
| 0.083 | 0.023 | 0.092 | Phosphodiesterase VII inhibitor | 0.092 0.017 DBMET00780 | DBMET00780 | |
| 0.069 | 0.01 | 0.069 | Histamine H2 receptor agonist | 0.066 0.012 DBMET01162 | ||
| 0.079 | 0.023 | 0.353 | Acyl-CoA dehydrogenase inhibitor | 0.352 0.001 DBMET00657 0.081 0.022 DBMET01162 0.307 0.001 DBMET01151 0.353 0.001 DBMET01158 0.28 0.002 DBMET01159 0.303 0.001 DBMET01152 0.281 0.002 DBMET01160 0.297 0.001 DBMET01153 0.327 0.001 DBMET01154 0.319 0.001 DBMET01155 0.287 0.002 DBMET01156 0.278 0.002 DBMET01157 | DBMET01158 | |
| 0.172 | 0.116 | 0.172 | Dyrk kinase inhibitor | 0.172 0.116 DBMET01162 | ||
| 0.059 | 0.004 | 0.059 | Alpha 2d adrenoreceptor agonist | 0.022 0.015 DBMET00780 0.046 0.005 DBMET01162 | ||
| 0.139 | 0.084 | 0.202 | Adenylate cyclase stimulant | 0.191 0.018 DBMET00657 0.135 0.091 DBMET01162 0.161 0.046 DBMET01151 0.193 0.017 DBMET01158 0.194 0.016 DBMET01159 0.202 0.013 DBMET01152 0.196 0.015 DBMET01160 0.187 0.02 DBMET01153 0.172 0.033 DBMET01154 0.163 0.044 DBMET01155 0.132 0.098 DBMET01156 0.122 0.121 DBMET01157 | DBMET01152 | |
| 0.06 | 0.008 | 0.06 | Histamine H1 receptor agonist | 0.056 0.011 DBMET01162 | ||
| 0.103 | 0.053 | 0.115 | MAP kinase kinase 1 inhibitor | 0.115 0.04 DBMET01162 | DBMET01162 | |
| 0.083 | 0.036 | 0.089 | MAP3K7 inhibitor | 0.089 0.03 DBMET01162 | DBMET01162 | |
| 0.106 | 0.059 | 0.106 | Platelet activating factor beta antagonist | |||
| 0.081 | 0.034 | 0.081 | Sirtuin 1 inhibitor | |||
| 0.111 | 0.066 | 0.111 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.125 | 0.081 | 0.222 | Lck kinase inhibitor | 0.222 0.032 DBMET01162 | DBMET01162 | |
| 0.095 | 0.051 | 0.421 | Phosphodiesterase I inhibitor | 0.291 0.005 DBMET00657 0.101 0.043 DBMET00780 0.295 0.005 DBMET01151 0.178 0.013 DBMET01158 0.116 0.029 DBMET01159 0.286 0.005 DBMET01152 0.153 0.017 DBMET01153 0.391 0.004 DBMET01154 0.421 0.003 DBMET01155 0.239 0.007 DBMET01156 0.267 0.005 DBMET01157 | DBMET01155 | |
| 0.101 | 0.06 | 0.107 | mTOR complex 1 inhibitor | 0.107 0.048 DBMET01162 | DBMET01162 | |
| 0.158 | 0.118 | 0.169 | Focal adhesion kinase 2 inhibitor | 0.169 0.102 DBMET01162 | DBMET01162 | |
| 0.116 | 0.075 | 0.772 | Aldehyde dehydrogenase inhibitor | 0.757 0.002 DBMET00657 0.137 0.056 DBMET01162 0.61 0.004 DBMET01151 0.772 0.002 DBMET01158 0.422 0.005 DBMET01159 0.487 0.004 DBMET01152 0.473 0.005 DBMET01160 0.486 0.004 DBMET01153 0.649 0.003 DBMET01154 0.602 0.004 DBMET01155 0.31 0.011 DBMET01156 0.268 0.015 DBMET01157 | DBMET01158 | |
| 0.081 | 0.04 | 0.844 | Phosphofructokinase-1 inhibitor | 0.844 0 DBMET00657 0.059 0.057 DBMET00780 0.07 0.048 DBMET01162 0.732 0.001 DBMET01151 0.761 0.001 DBMET01158 0.649 0.001 DBMET01159 0.723 0.001 DBMET01152 0.544 0.002 DBMET01160 0.673 0.001 DBMET01153 0.802 0.001 DBMET01154 0.826 0.001 DBMET01155 0.643 0.001 DBMET01156 0.669 0.001 DBMET01157 | DBMET00657 | |
| 0.18 | 0.141 | 0.18 | Superoxide dismutase inhibitor | |||
| 0.115 | 0.076 | 0.258 | MAP kinase 12 inhibitor | 0.258 0.011 DBMET01162 | DBMET01162 | |
| 0.134 | 0.097 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.133 0.103 DBMET01162 | ||
| 0.256 | 0.22 | 0.282 | 5 Hydroxytryptamine release inhibitor | 0.282 0.187 DBMET01162 | DBMET01162 | |
| 0.106 | 0.069 | 0.113 | EphA2 antagonist | 0.113 0.062 DBMET01162 | DBMET01162 | |
| 0.19 | 0.154 | 0.221 | Tyrosine 3 hydroxylase inhibitor | 0.221 0.102 DBMET01162 | DBMET01162 | |
| 0.087 | 0.053 | 0.087 | mTOR complex 2 inhibitor | 0.083 0.062 DBMET01162 | ||
| 0.068 | 0.034 | 0.534 | Purinergic P2X1 antagonist | 0.513 0 DBMET00657 0.069 0.032 DBMET00780 0.061 0.042 DBMET01161 0.087 0.021 DBMET01162 0.51 0 DBMET01151 0.534 0 DBMET01158 0.268 0.002 DBMET01159 0.354 0.001 DBMET01152 0.286 0.002 DBMET01160 0.374 0.001 DBMET01153 0.428 0.001 DBMET01154 0.45 0.001 DBMET01155 0.351 0.001 DBMET01156 0.376 0.001 DBMET01157 | DBMET01158 | |
| 0.056 | 0.022 | 0.056 | Histamine H4 receptor antagonist | 0.05 0.031 DBMET01162 | ||
| 0.097 | 0.064 | 0.603 | UDP-glucose 4-epimerase inhibitor | 0.603 0.001 DBMET00657 0.086 0.08 DBMET00780 0.087 0.078 DBMET01162 0.571 0.001 DBMET01151 0.591 0.001 DBMET01158 0.506 0.003 DBMET01159 0.541 0.002 DBMET01152 0.491 0.003 DBMET01160 0.514 0.002 DBMET01153 0.578 0.001 DBMET01154 0.59 0.001 DBMET01155 0.569 0.001 DBMET01156 0.581 0.001 DBMET01157 | DBMET00657 | |
| 0.152 | 0.12 | 0.194 | MAP kinase kinase 2 inhibitor | 0.194 0.085 DBMET01162 | DBMET01162 | |
| 0.037 | 0.006 | 0.291 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.067 0.003 DBMET00657 0.036 0.007 DBMET00780 0.039 0.005 DBMET01162 0.088 0.003 DBMET01151 0.062 0.003 DBMET01158 0.079 0.003 DBMET01159 0.291 0.001 DBMET01152 0.072 0.003 DBMET01160 0.272 0.001 DBMET01153 0.119 0.002 DBMET01154 0.091 0.002 DBMET01155 0.156 0.002 DBMET01156 0.127 0.002 DBMET01157 | DBMET01152 | |
| 0.035 | 0.004 | 0.035 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.033 0.004 DBMET00780 0.03 0.004 DBMET01162 0.029 0.005 DBMET01159 0.028 0.005 DBMET01160 | ||
| 0.057 | 0.026 | 0.103 | Adenosine A2b receptor antagonist | 0.059 0.025 DBMET01162 0.082 0.014 DBMET01159 0.103 0.01 DBMET01160 | DBMET01160 | |
| 0.09 | 0.059 | 0.21 | Triose-phosphate isomerase inhibitor | 0.158 0.018 DBMET00657 0.08 0.077 DBMET00780 0.133 0.026 DBMET01151 0.21 0.01 DBMET01158 0.167 0.016 DBMET01152 0.089 0.061 DBMET01160 0.125 0.03 DBMET01153 0.096 0.052 DBMET01154 0.087 0.064 DBMET01155 | DBMET01158 | |
| 0.063 | 0.036 | 0.309 | Xanthine dehydrogenase inhibitor | 0.105 0.014 DBMET00780 0.309 0.003 DBMET01161 0.066 0.034 DBMET01159 | DBMET01161 | |
| 0.074 | 0.047 | 0.074 | Histidine decarboxylase inhibitor | 0.067 0.054 DBMET00780 0.062 0.06 DBMET01162 | ||
| 0.056 | 0.029 | 0.056 | Carbonic anhydrase II stimulant | 0.053 0.034 DBMET01162 | ||
| 0.084 | 0.058 | 0.084 | Myeloperoxidase inhibitor | |||
| 0.035 | 0.01 | 0.081 | Purinergic P2Y15 antagonist | 0.053 0.003 DBMET00657 0.027 0.024 DBMET00780 0.033 0.013 DBMET01162 0.036 0.009 DBMET01151 0.05 0.004 DBMET01158 0.081 0.001 DBMET01159 0.038 0.008 DBMET01152 0.077 0.002 DBMET01160 0.033 0.012 DBMET01153 0.031 0.016 DBMET01154 0.028 0.021 DBMET01155 | DBMET01159 | |
| 0.144 | 0.121 | 0.144 | Death-associated protein kinase 2 inhibitor | |||
| 0.062 | 0.039 | 0.062 | Carbonic anhydrase stimulant | 0.056 0.045 DBMET01162 | ||
| 0.068 | 0.046 | 0.068 | CDC7 inhibitor | |||
| 0.063 | 0.042 | 0.063 | Histone deacetylase SIRT3 inhibitor | 0.059 0.053 DBMET01162 | ||
| 0.03 | 0.01 | 0.07 | Alpha 1a adrenoreceptor agonist | 0.07 0.004 DBMET01162 | DBMET01162 | |
| 0.054 | 0.036 | 0.833 | Ornithine carbamoyltransferase inhibitor | 0.813 0.001 DBMET00657 0.067 0.027 DBMET01162 0.716 0.001 DBMET01151 0.763 0.001 DBMET01158 0.368 0.004 DBMET01159 0.74 0.001 DBMET01152 0.28 0.005 DBMET01160 0.76 0.001 DBMET01153 0.815 0.001 DBMET01154 0.833 0.001 DBMET01155 0.566 0.002 DBMET01156 0.622 0.002 DBMET01157 | DBMET01155 | |
| 0.032 | 0.014 | 0.032 | MAP3K8 inhibitor | 0.031 0.016 DBMET01162 | ||
| 0.028 | 0.011 | 0.967 | Adenosine kinase inhibitor | 0.967 0 DBMET00657 0.603 0.001 DBMET01151 0.947 0 DBMET01158 0.904 0 DBMET01159 0.555 0.001 DBMET01152 0.835 0.001 DBMET01160 0.328 0.001 DBMET01153 0.716 0.001 DBMET01154 0.765 0.001 DBMET01155 0.638 0.001 DBMET01156 0.678 0.001 DBMET01157 | DBMET00657 | |
| 0.028 | 0.011 | 0.041 | Complement factor 1s inhibitor | 0.041 0.004 DBMET01162 | DBMET01162 | |
| 0.023 | 0.007 | 0.023 | Alpha 2b adrenoreceptor agonist | 0.018 0.014 DBMET01162 | ||
| 0.019 | 0.006 | 0.024 | CDK2/cyclin A3 inhibitor | 0.024 0.004 DBMET01162 | DBMET01162 | |
| 0.051 | 0.038 | 0.051 | Histamine agonist | |||
| 0.024 | 0.011 | 0.024 | Glutaminyl-peptide cyclotransferase inhibitor | 0.022 0.014 DBMET01162 | ||
| 0.022 | 0.009 | 0.035 | Alpha 2c adrenoreceptor agonist | 0.035 0.004 DBMET01162 | DBMET01162 | |
| 0.044 | 0.032 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | 0.05 0.025 DBMET01162 0.044 0.033 DBMET01158 | DBMET01162 | |
| 0.016 | 0.004 | 0.436 | Purine nucleoside phosphorylase inhibitor | 0.104 0.001 DBMET00657 0.015 0.005 DBMET00780 0.014 0.005 DBMET01161 0.04 0.002 DBMET01162 0.036 0.002 DBMET01151 0.045 0.002 DBMET01158 0.051 0.002 DBMET01159 0.079 0.001 DBMET01152 0.026 0.003 DBMET01160 0.436 0.001 DBMET01153 0.133 0.001 DBMET01154 0.107 0.001 DBMET01155 0.038 0.002 DBMET01156 0.03 0.002 DBMET01157 | DBMET01153 | |
| 0.166 | 0.155 | 0.166 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.033 | 0.023 | 0.036 | ATR kinase inhibitor | 0.036 0.017 DBMET01162 | DBMET01162 | |
| 0.038 | 0.029 | 0.04 | MAP3K5 inhibitor | 0.04 0.026 DBMET01162 | DBMET01162 | |
| 0.056 | 0.048 | 0.097 | Alpha 2 adrenoreceptor agonist | 0.097 0.016 DBMET01162 | DBMET01162 | |
| 0.036 | 0.028 | 0.036 | Somatostatin 4 agonist | |||
| 0.03 | 0.023 | 0.03 | Potassium channel small-conductance Ca-activated activator | |||
| 0.087 | 0.08 | 0.099 | Electrolyte absorption antagonist | 0.099 0.059 DBMET01162 | DBMET01162 | |
| 0.019 | 0.012 | 0.019 | Histamine H4 receptor agonist | |||
| 0.075 | 0.068 | 0.075 | AXL receptor tyrosine kinase inhibitor | |||
| 0.026 | 0.019 | 0.1 | Thymidine phosphorylase inhibitor | 0.048 0.005 DBMET00657 0.037 0.008 DBMET00780 0.029 0.014 DBMET01161 0.1 0.003 DBMET01151 0.045 0.005 DBMET01158 0.065 0.004 DBMET01159 0.087 0.003 DBMET01152 0.06 0.004 DBMET01160 0.047 0.005 DBMET01153 0.05 0.005 DBMET01154 0.043 0.006 DBMET01155 0.053 0.004 DBMET01156 0.045 0.005 DBMET01157 | DBMET01151 | |
| 0.041 | 0.036 | 0.086 | Geranyltranstransferase inhibitor | 0.056 0.017 DBMET00657 0.051 0.021 DBMET01162 0.086 0.004 DBMET01158 0.055 0.018 DBMET01160 0.06 0.013 DBMET01154 0.054 0.019 DBMET01155 0.04 0.037 DBMET01156 | DBMET01158 | |
| 0.012 | 0.008 | 0.012 | Egl nine homolog 2 inhibitor | |||
| 0.084 | 0.08 | 0.084 | Creatine kinase inhibitor | |||
| 0.01 | 0.007 | 0.01 | CXC chemokine 3 receptor agonist | |||
| 0.061 | 0.058 | 0.07 | Syk tyrosine kinase inhibitor | 0.07 0.05 DBMET01162 | DBMET01162 | |
| 0.031 | 0.029 | 0.031 | Transforming growth factor beta 2 antagonist | |||
| 0.056 | 0.053 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.129 | 0.127 | 0.743 | Heat shock protein 70 antagonist | 0.467 0.002 DBMET00657 0.144 0.061 DBMET01162 0.278 0.004 DBMET01151 0.743 0.001 DBMET01158 0.209 0.005 DBMET01159 0.384 0.003 DBMET01152 0.392 0.003 DBMET01160 0.437 0.002 DBMET01153 0.657 0.002 DBMET01154 0.703 0.001 DBMET01155 0.337 0.003 DBMET01156 0.382 0.003 DBMET01157 | DBMET01158 | |
| 0.06 | 0.058 | 0.071 | Phenylalanine 4-hydroxylase inhibitor | 0.07 0.046 DBMET01161 0.071 0.046 DBMET01162 | DBMET01162 | |
| 0.072 | 0.071 | 0.072 | ALK inhibitor | |||
| 0.017 | 0.016 | 0.057 | Methylmalonyl-CoA mutase inhibitor | 0.056 0 DBMET00657 0.017 0.015 DBMET01162 0.043 0.001 DBMET01151 0.057 0 DBMET01158 0.037 0.001 DBMET01159 0.042 0.001 DBMET01152 0.037 0.001 DBMET01160 0.041 0.001 DBMET01153 0.049 0.001 DBMET01154 0.047 0.001 DBMET01155 0.039 0.001 DBMET01156 0.037 0.001 DBMET01157 | DBMET01158 | |
| 0.082 | 0.081 | 0.512 | DNA directed RNA polymerase inhibitor | 0.221 0.011 DBMET00657 0.083 0.08 DBMET00780 0.213 0.012 DBMET01151 0.271 0.008 DBMET01158 0.112 0.044 DBMET01159 0.297 0.007 DBMET01152 0.16 0.021 DBMET01160 0.21 0.012 DBMET01153 0.436 0.004 DBMET01154 0.494 0.004 DBMET01155 0.46 0.004 DBMET01156 0.512 0.004 DBMET01157 | DBMET01157 | |
| 0.132 | 0.131 | 0.184 | Clk dual-specificity kinase inhibitor | 0.184 0.089 DBMET01162 | DBMET01162 | |
| 0.006 | 0.006 | 0.008 | DNA polymerase III subunit alpha inhibitor | 0.008 0.004 DBMET01162 | DBMET01162 | |
| 0.014 | 0.015 | 0.22 | Adenosine A2 receptor agonist | 0.064 0.003 DBMET00657 0.038 0.004 DBMET01151 0.108 0.003 DBMET01158 0.195 0.001 DBMET01159 0.043 0.004 DBMET01152 0.22 0.001 DBMET01160 0.035 0.005 DBMET01153 0.023 0.007 DBMET01154 0.02 0.008 DBMET01155 | DBMET01160 | |
| 0.013 | 0.013 | 0.144 | Adenosine A2a receptor agonist | 0.047 0.003 DBMET00657 0.013 0.012 DBMET01162 0.04 0.004 DBMET01151 0.057 0.002 DBMET01158 0.096 0.001 DBMET01159 0.044 0.003 DBMET01152 0.144 0.001 DBMET01160 0.042 0.003 DBMET01153 0.03 0.005 DBMET01154 0.026 0.006 DBMET01155 | DBMET01160 | |
| 0.014 | 0.015 | 0.235 | Purinergic P2Y1 agonist | 0.202 0 DBMET00657 0.02 0.007 DBMET01162 0.167 0 DBMET01151 0.235 0 DBMET01158 0.1 0.001 DBMET01159 0.158 0.001 DBMET01152 0.145 0.001 DBMET01160 0.189 0 DBMET01153 0.178 0 DBMET01154 0.185 0 DBMET01155 0.172 0 DBMET01156 0.178 0 DBMET01157 | DBMET01158 | |
| 0.064 | 0.068 | 0.07 | CYP2A6 inhibitor | 0.07 0.059 DBMET01162 | DBMET01162 | |
| 0.09 | 0.094 | 0.715 | Adenylate cyclase inhibitor | 0.67 0.002 DBMET00657 0.146 0.048 DBMET01162 0.619 0.003 DBMET01151 0.692 0.002 DBMET01158 0.559 0.004 DBMET01159 0.657 0.002 DBMET01152 0.61 0.004 DBMET01160 0.674 0.002 DBMET01153 0.699 0.002 DBMET01154 0.713 0.001 DBMET01155 0.702 0.002 DBMET01156 0.715 0.001 DBMET01157 | DBMET01157 | |
| 0.073 | 0.077 | 0.096 | CDK/cyclin complex inhibitor | 0.096 0.055 DBMET01162 | DBMET01162 | |
| 0.008 | 0.013 | 0.282 | Purinergic P2Y2 agonist | 0.046 0.001 DBMET00657 0.041 0.001 DBMET01151 0.113 0 DBMET01158 0.019 0.002 DBMET01159 0.118 0 DBMET01152 0.027 0.001 DBMET01160 0.072 0 DBMET01153 0.237 0 DBMET01154 0.282 0 DBMET01155 0.169 0 DBMET01156 0.215 0 DBMET01157 | DBMET01155 | |
| 0.013 | 0.019 | 0.05 | Alpha 2a adrenoreceptor agonist | 0.05 0.004 DBMET01162 | DBMET01162 | |
| 0.009 | 0.016 | 0.012 | Egl nine homolog 3 inhibitor | 0.012 0.009 DBMET00780 | DBMET00780 | |
| 0.037 | 0.046 | 0.245 | Thymidylate synthase inhibitor | 0.097 0.005 DBMET00657 0.092 0.005 DBMET01151 0.091 0.005 DBMET01158 0.042 0.038 DBMET01159 0.245 0.002 DBMET01152 0.166 0.003 DBMET01153 0.131 0.003 DBMET01154 0.115 0.004 DBMET01155 0.162 0.003 DBMET01156 0.141 0.003 DBMET01157 | DBMET01152 | |
| 0.107 | 0.115 | 0.124 | Activin receptor-like kinase 2 inhibitor | 0.124 0.092 DBMET01162 | DBMET01162 | |
| 0.026 | 0.036 | 0.863 | Fumarate hydratase inhibitor | 0.83 0.001 DBMET00657 0.737 0.001 DBMET01151 0.812 0.001 DBMET01158 0.36 0.002 DBMET01159 0.792 0.001 DBMET01152 0.295 0.003 DBMET01160 0.742 0.001 DBMET01153 0.848 0.001 DBMET01154 0.863 0.001 DBMET01155 0.674 0.001 DBMET01156 0.719 0.001 DBMET01157 | DBMET01155 | |
| 0.019 | 0.029 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.02 DBMET01162 | DBMET01162 | |
| 0.001 | 0.013 | 0.071 | Purinergic P2Y6 agonist | 0.01 0.001 DBMET00657 0.011 0.001 DBMET01151 0.014 0.001 DBMET01158 0.003 0.002 DBMET01159 0.025 0 DBMET01152 0.004 0.002 DBMET01160 0.013 0.001 DBMET01153 0.055 0 DBMET01154 0.071 0 DBMET01155 0.039 0 DBMET01156 0.05 0 DBMET01157 | DBMET01155 | |
| 0.026 | 0.04 | 0.56 | Phosphoglycerate kinase inhibitor | 0.528 0.001 DBMET00657 0.47 0.001 DBMET01151 0.52 0.001 DBMET01158 0.432 0.001 DBMET01159 0.523 0.001 DBMET01152 0.413 0.002 DBMET01160 0.506 0.001 DBMET01153 0.549 0 DBMET01154 0.56 0 DBMET01155 0.477 0.001 DBMET01156 0.491 0.001 DBMET01157 | DBMET01155 | |
| 0.092 | 0.105 | 0.137 | MAP kinase kinase inhibitor | 0.137 0.059 DBMET01162 | DBMET01162 | |
| 0.048 | 0.063 | 0.083 | Cyclin A2 inhibitor | 0.083 0.031 DBMET01162 | DBMET01162 | |
| 0.102 | 0.119 | 0.129 | CDC-like kinase 1 inhibitor | 0.129 0.087 DBMET01162 | DBMET01162 | |
| 0.052 | 0.069 | 0.104 | Alpha adrenoreceptor agonist | 0.104 0.026 DBMET01162 | DBMET01162 | |
| 0.051 | 0.071 | 0.099 | Corticotropin releasing factor 2 receptor antagonist | 0.068 0.031 DBMET00657 0.069 0.029 DBMET01162 0.099 0.007 DBMET01158 0.063 0.039 DBMET01154 0.07 0.028 DBMET01155 | DBMET01158 | |
| 0.01 | 0.03 | 0.211 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.103 0.003 DBMET00657 0.038 0.004 DBMET01151 0.088 0.003 DBMET01158 0.211 0.002 DBMET01159 0.028 0.005 DBMET01152 0.202 0.002 DBMET01160 0.027 0.005 DBMET01153 0.024 0.005 DBMET01154 0.023 0.006 DBMET01155 0.019 0.007 DBMET01156 0.018 0.007 DBMET01157 | DBMET01159 | |
| 0.105 | 0.126 | 0.164 | Cell wall synthesis inhibitor | 0.164 0.053 DBMET01162 0.123 0.095 DBMET01158 0.124 0.094 DBMET01152 0.123 0.096 DBMET01160 0.138 0.077 DBMET01153 0.123 0.095 DBMET01154 | DBMET01162 | |
| 0.006 | 0.027 | 0.408 | Purinergic P2Y agonist | 0.121 0.001 DBMET00657 0.123 0.001 DBMET01151 0.12 0.001 DBMET01158 0.043 0.003 DBMET01159 0.103 0.001 DBMET01152 0.044 0.003 DBMET01160 0.092 0.001 DBMET01153 0.273 0.001 DBMET01154 0.408 0.001 DBMET01155 0.19 0.001 DBMET01156 0.255 0.001 DBMET01157 | DBMET01155 | |
| 0.006 | 0.027 | 0.424 | Purinergic P2 agonist | 0.132 0.001 DBMET00657 0.133 0.001 DBMET01151 0.13 0.001 DBMET01158 0.051 0.003 DBMET01159 0.112 0.001 DBMET01152 0.052 0.003 DBMET01160 0.101 0.001 DBMET01153 0.295 0.001 DBMET01154 0.424 0.001 DBMET01155 0.211 0.001 DBMET01156 0.277 0.001 DBMET01157 | DBMET01155 | |
| 0.006 | 0.027 | 0.424 | Purinergic receptor agonist | 0.132 0.001 DBMET00657 0.133 0.001 DBMET01151 0.13 0.001 DBMET01158 0.051 0.003 DBMET01159 0.112 0.001 DBMET01152 0.052 0.003 DBMET01160 0.101 0.001 DBMET01153 0.295 0.001 DBMET01154 0.424 0.001 DBMET01155 0.211 0.001 DBMET01156 0.277 0.001 DBMET01157 | DBMET01155 | |
| 0.029 | 0.054 | 0.63 | Purinergic P2Y antagonist | 0.487 0.002 DBMET00657 0.067 0.016 DBMET00780 0.057 0.021 DBMET01161 0.571 0.001 DBMET01151 0.63 0.001 DBMET01158 0.155 0.005 DBMET01159 0.412 0.002 DBMET01152 0.303 0.003 DBMET01160 0.398 0.002 DBMET01153 0.488 0.002 DBMET01154 0.518 0.001 DBMET01155 0.45 0.002 DBMET01156 0.479 0.002 DBMET01157 | DBMET01158 | |
| 0.037 | 0.062 | 0.089 | Glucose-6-phosphate isomerase inhibitor | 0.089 0.006 DBMET00657 0.08 0.009 DBMET01151 0.083 0.008 DBMET01158 0.05 0.029 DBMET01159 0.063 0.016 DBMET01152 0.047 0.035 DBMET01160 0.055 0.023 DBMET01153 0.044 0.041 DBMET01154 | DBMET00657 | |
| 0.041 | 0.069 | 0.072 | Cyclin A inhibitor | 0.072 0.036 DBMET01162 | DBMET01162 | |
| 0.013 | 0.044 | 0.343 | Purinergic P2X agonist | 0.222 0.001 DBMET00657 0.188 0.002 DBMET01151 0.223 0.001 DBMET01158 0.088 0.004 DBMET01159 0.163 0.002 DBMET01152 0.09 0.004 DBMET01160 0.158 0.002 DBMET01153 0.289 0.001 DBMET01154 0.343 0.001 DBMET01155 0.214 0.001 DBMET01156 0.266 0.001 DBMET01157 | DBMET01155 | |
| 0.035 | 0.066 | 0.054 | mTOR inhibitor | 0.054 0.034 DBMET01162 | DBMET01162 | |
| 0.009 | 0.04 | 0.304 | Adenosine A2b receptor agonist | 0.041 0.003 DBMET00657 0.036 0.003 DBMET01151 0.039 0.003 DBMET01158 0.304 0.002 DBMET01159 0.029 0.004 DBMET01152 0.271 0.002 DBMET01160 0.026 0.004 DBMET01153 0.025 0.004 DBMET01154 0.025 0.004 DBMET01155 0.016 0.008 DBMET01156 0.016 0.008 DBMET01157 | DBMET01159 | |
| 0.012 | 0.044 | 0.584 | Adenosine A1 receptor agonist | 0.384 0.002 DBMET00657 0.238 0.003 DBMET01151 0.371 0.002 DBMET01158 0.584 0.002 DBMET01159 0.155 0.003 DBMET01152 0.568 0.002 DBMET01160 0.125 0.003 DBMET01153 0.107 0.004 DBMET01154 0.099 0.004 DBMET01155 0.054 0.005 DBMET01156 0.052 0.005 DBMET01157 | DBMET01159 | |
| 0.029 | 0.061 | 0.919 | Phosphodiesterase 3B inhibitor | 0.51 0.002 DBMET00780 0.919 0.001 DBMET01161 0.042 0.033 DBMET01162 0.313 0.004 DBMET01151 | DBMET01161 | |
| 0.047 | 0.079 | 0.07 | Janus tyrosine kinase 3 inhibitor | 0.07 0.052 DBMET01162 | DBMET01162 | |
| 0.073 | 0.106 | 0.105 | Cyclin-dependent kinase 9 inhibitor | 0.105 0.057 DBMET01162 | DBMET01162 | |
| 0.03 | 0.064 | 0.338 | Ribonucleotide reductase inhibitor | 0.252 0.005 DBMET00657 0.266 0.005 DBMET01151 0.186 0.008 DBMET01158 0.154 0.011 DBMET01159 0.201 0.007 DBMET01152 0.113 0.018 DBMET01160 0.156 0.011 DBMET01153 0.27 0.005 DBMET01154 0.307 0.004 DBMET01155 0.312 0.004 DBMET01156 0.338 0.004 DBMET01157 | DBMET01157 | |
| 0.03 | 0.064 | 0.2 | Ribonucleoside-diphosphate reductase inhibitor | 0.193 0.007 DBMET00657 0.2 0.007 DBMET01151 0.148 0.011 DBMET01158 0.138 0.013 DBMET01159 0.15 0.011 DBMET01152 0.093 0.021 DBMET01160 0.111 0.017 DBMET01153 0.162 0.01 DBMET01154 0.151 0.011 DBMET01155 0.17 0.009 DBMET01156 0.158 0.01 DBMET01157 | DBMET01151 | |
| 0.055 | 0.09 | 0.105 | Leucine-rich repeat kinase 2 inhibitor | 0.105 0.04 DBMET01162 | DBMET01162 | |
| 0.045 | 0.084 | 0.075 | Heat shock protein 90 beta antagonist | 0.075 0.024 DBMET01162 | DBMET01162 | |
| 0.049 | 0.091 | 0.076 | Phosphodiesterase 1C inhibitor | 0.076 0.023 DBMET00780 | DBMET00780 | |
| 0 | 0.042 | 0.119 | Purinergic P2Y4 agonist | 0.015 0.001 DBMET00657 0.013 0.001 DBMET01151 0.015 0.001 DBMET01158 0.015 0.001 DBMET01152 0.004 0.003 DBMET01160 0.013 0.001 DBMET01153 0.06 0.001 DBMET01154 0.119 0 DBMET01155 0.038 0.001 DBMET01156 0.062 0.001 DBMET01157 | DBMET01155 | |
| 0.147 | 0.191 | 0.172 | ErbB-1 antagonist | 0.172 0.13 DBMET01162 | DBMET01162 | |
| 0.01 | 0.055 | 0.02 | Hexokinase stimulant | 0.02 0.014 DBMET01162 | DBMET01162 | |
| 0.01 | 0.057 | 0.266 | Adenosine A3 receptor agonist | 0.092 0.003 DBMET00657 0.061 0.004 DBMET01151 0.088 0.003 DBMET01158 0.266 0.002 DBMET01159 0.062 0.004 DBMET01152 0.26 0.002 DBMET01160 0.056 0.004 DBMET01153 0.046 0.004 DBMET01154 0.041 0.004 DBMET01155 0.023 0.007 DBMET01156 0.022 0.007 DBMET01157 | DBMET01159 | |
| 0.162 | 0.209 | 0.474 | Transcription factor STAT inhibitor | 0.33 0.041 DBMET00657 0.194 0.147 DBMET01162 0.474 0.01 DBMET01158 0.258 0.081 DBMET01160 | DBMET01158 | |
| 0.121 | 0.177 | 0.139 | Succinate dehydrogenase inhibitor | 0.139 0.134 DBMET01161 | DBMET01161 | |
| 0.023 | 0.082 | 0.09 | Guanylate cyclase inhibitor | 0.09 0.002 DBMET00657 0.084 0.002 DBMET01151 0.086 0.002 DBMET01158 0.077 0.003 DBMET01159 0.078 0.003 DBMET01152 0.071 0.005 DBMET01160 0.076 0.004 DBMET01153 0.084 0.002 DBMET01154 0.086 0.002 DBMET01155 0.084 0.002 DBMET01156 0.086 0.002 DBMET01157 | DBMET00657 | |
| 0.035 | 0.096 | 0.089 | Cytokine production stimulant | 0.055 0.019 DBMET00657 0.066 0.009 DBMET01161 0.049 0.031 DBMET01151 0.089 0.004 DBMET01159 0.055 0.019 DBMET01160 | DBMET01159 | |
| 0.121 | 0.185 | 0.703 | Immunostimulant | 0.673 0.01 DBMET00657 0.191 0.126 DBMET00780 0.318 0.074 DBMET01161 0.703 0.008 DBMET01151 0.597 0.017 DBMET01158 0.59 0.018 DBMET01159 0.67 0.01 DBMET01152 0.481 0.031 DBMET01160 0.607 0.016 DBMET01153 0.671 0.01 DBMET01154 0.656 0.011 DBMET01155 0.66 0.011 DBMET01156 0.644 0.012 DBMET01157 | DBMET01151 | |
| 0.036 | 0.102 | 0.059 | Bombesin 1 receptor agonist | 0.059 0.042 DBMET01162 | DBMET01162 | |
| 0.031 | 0.098 | 0.067 | Alpha 1 adrenoreceptor agonist | 0.067 0.03 DBMET01162 | DBMET01162 | |
| 0.094 | 0.165 | 0.165 | CDC-like kinase 4 inhibitor | 0.165 0.089 DBMET01162 | DBMET01162 | |
| 0.011 | 0.089 | 0.043 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 DBMET00657 0.024 0.012 DBMET01158 0.04 0.003 DBMET01159 0.043 0.003 DBMET01160 | DBMET01160 | |
| 0.005 | 0.089 | 0.028 | Progesterone agonist | 0.028 0.007 DBMET01161 | DBMET01161 | |
| 0.017 | 0.101 | 0.036 | Toll-Like receptor 2 agonist | 0.036 0.033 DBMET01160 | DBMET01160 | |
| 0.162 | 0.252 | 0.253 | 5 Hydroxytryptamine uptake stimulant | 0.253 0.078 DBMET01162 | DBMET01162 | |
| 0.063 | 0.158 | 0.109 | Glycogen synthase kinase-3 alpha inhibitor | 0.109 0.095 DBMET01162 | DBMET01162 | |
| 0.057 | 0.156 | 0.094 | Cyclin-dependent kinase 2 inhibitor | 0.094 0.077 DBMET01162 | DBMET01162 | |
| 0.207 | 0.31 | 0.551 | Caspase 9 stimulant | 0.418 0.101 DBMET00657 0.324 0.168 DBMET01151 0.551 0.045 DBMET01158 0.257 0.244 DBMET01159 0.495 0.062 DBMET01152 0.371 0.13 DBMET01160 0.421 0.099 DBMET01153 0.292 0.202 DBMET01154 0.255 0.247 DBMET01155 | DBMET01158 | |
| 0.038 | 0.145 | 0.065 | Phospholipase D inhibitor | 0.065 0.064 DBMET01161 | DBMET01161 | |
| 0.04 | 0.148 | 0.071 | Interferon inducer | 0.066 0.041 DBMET00780 0.071 0.034 DBMET01161 | DBMET01161 | |
| 0.009 | 0.119 | 0.025 | Complement factor 1 inhibitor | 0.025 0.005 DBMET01162 | DBMET01162 | |
| 0.054 | 0.166 | 0.354 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.354 0.004 DBMET00657 0.321 0.005 DBMET01151 0.334 0.005 DBMET01158 0.139 0.03 DBMET01159 0.311 0.005 DBMET01152 0.129 0.035 DBMET01160 0.261 0.009 DBMET01153 0.346 0.005 DBMET01154 0.311 0.005 DBMET01155 0.162 0.023 DBMET01156 0.139 0.03 DBMET01157 | DBMET00657 | |
| 0.04 | 0.157 | 0.085 | Protein kinase B gamma inhibitor | 0.085 0.043 DBMET00780 | DBMET00780 | |
| 0.162 | 0.28 | 0.279 | Calcium channel activator | 0.269 0.125 DBMET01162 0.279 0.114 DBMET01158 0.23 0.171 DBMET01153 | DBMET01158 | |
| 0.007 | 0.129 | 0.052 | Calcitonin gene-related peptide antagonist | 0.048 0.011 DBMET00780 0.052 0.01 DBMET01161 | DBMET01161 | |
| 0.017 | 0.144 | 0.046 | Mannosidase inhibitor | 0.046 0.03 DBMET01159 | DBMET01159 | |
| 0.013 | 0.14 | 0.376 | Inosine monophosphate dehydrogenase inhibitor | 0.318 0.002 DBMET00657 0.366 0.002 DBMET01151 0.338 0.002 DBMET01158 0.082 0.006 DBMET01159 0.33 0.002 DBMET01152 0.091 0.005 DBMET01160 0.246 0.003 DBMET01153 0.376 0.002 DBMET01154 0.319 0.002 DBMET01155 0.133 0.004 DBMET01156 0.113 0.005 DBMET01157 | DBMET01154 | |
| 0.005 | 0.132 | 0.255 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.222 0.002 DBMET00657 0.255 0.002 DBMET01151 0.203 0.002 DBMET01158 0.039 0.005 DBMET01159 0.188 0.002 DBMET01152 0.034 0.006 DBMET01160 0.141 0.002 DBMET01153 0.219 0.002 DBMET01154 0.184 0.002 DBMET01155 0.069 0.004 DBMET01156 0.056 0.004 DBMET01157 | DBMET01151 | |
| 0.024 | 0.151 | 0.054 | Alpha-mannosidase inhibitor | 0.054 0.036 DBMET01159 0.053 0.038 DBMET01160 | DBMET01159 | |
| 0.056 | 0.186 | 0.259 | Amylase inhibitor | 0.259 0.026 DBMET01159 0.21 0.041 DBMET01160 | DBMET01159 | |
| 0.052 | 0.183 | 0.122 | Anabolic | 0.122 0.038 DBMET00657 0.103 0.059 DBMET01151 0.1 0.063 DBMET01158 0.09 0.078 DBMET01154 0.097 0.067 DBMET01155 | DBMET00657 | |
| 0.04 | 0.172 | 0.095 | Interferon agonist | 0.077 0.057 DBMET00780 0.095 0.033 DBMET01161 | DBMET01161 | |
| 0.079 | 0.21 | 0.497 | Pyruvate kinase inhibitor | 0.497 0.009 DBMET00657 0.388 0.023 DBMET01151 0.372 0.027 DBMET01158 0.181 0.093 DBMET01152 0.204 0.079 DBMET01153 0.298 0.048 DBMET01154 0.342 0.036 DBMET01155 | DBMET00657 | |
| 0.08 | 0.213 | 0.303 | Mannose-6-phosphate isomerase inhibitor | 0.251 0.012 DBMET00657 0.148 0.066 DBMET01161 0.303 0.005 DBMET01151 0.134 0.08 DBMET01158 0.115 0.11 DBMET01152 | DBMET01151 | |
| 0.007 | 0.141 | 0.073 | Uridine phosphorylase inhibitor | 0.049 0.008 DBMET00657 0.073 0.004 DBMET01151 0.046 0.009 DBMET01158 0.029 0.019 DBMET01159 0.051 0.008 DBMET01152 0.026 0.021 DBMET01160 0.041 0.011 DBMET01153 | DBMET01151 | |
| 0.025 | 0.163 | 0.357 | HIV-1 reverse transcriptase inhibitor | 0.194 0.01 DBMET00657 0.074 0.046 DBMET00780 0.158 0.013 DBMET01161 0.155 0.013 DBMET01162 0.216 0.009 DBMET01151 0.133 0.018 DBMET01158 0.114 0.024 DBMET01159 0.139 0.016 DBMET01152 0.195 0.01 DBMET01153 0.29 0.005 DBMET01154 0.345 0.005 DBMET01155 0.305 0.005 DBMET01156 0.357 0.005 DBMET01157 | DBMET01157 | |
| 0.059 | 0.203 | 0.437 | Phosphodiesterase inhibitor | 0.231 0.026 DBMET00780 0.437 0.005 DBMET01161 | DBMET01161 | |
| 0.046 | 0.19 | 0.596 | Aminoacyl-tRNA synthetase inhibitor | 0.547 0.003 DBMET00657 0.484 0.003 DBMET01151 0.49 0.003 DBMET01158 0.437 0.004 DBMET01159 0.418 0.004 DBMET01152 0.387 0.004 DBMET01160 0.407 0.004 DBMET01153 0.546 0.003 DBMET01154 0.596 0.003 DBMET01155 0.477 0.003 DBMET01156 0.523 0.003 DBMET01157 | DBMET01155 | |
| 0.023 | 0.169 | 0.318 | Purinergic P2X4 antagonist | 0.246 0.003 DBMET00657 0.125 0.004 DBMET01151 0.318 0.002 DBMET01158 0.119 0.004 DBMET01152 0.047 0.029 DBMET01160 0.11 0.004 DBMET01153 0.225 0.003 DBMET01154 0.271 0.003 DBMET01155 0.078 0.007 DBMET01156 0.091 0.005 DBMET01157 | DBMET01158 | |
| 0.074 | 0.221 | 0.485 | Transcription factor STAT6 inhibitor | 0.254 0.005 DBMET00657 0.138 0.034 DBMET01151 0.485 0.002 DBMET01158 0.171 0.013 DBMET01159 0.156 0.019 DBMET01152 0.39 0.003 DBMET01160 0.172 0.012 DBMET01153 0.117 0.065 DBMET01154 0.105 0.093 DBMET01155 | DBMET01158 | |
| 0.072 | 0.224 | 0.153 | Diuretic | 0.153 0.075 DBMET01162 | DBMET01162 | |
| 0.057 | 0.217 | 0.131 | CDC-like kinase 2 inhibitor | 0.131 0.109 DBMET01162 | DBMET01162 | |
| 0.039 | 0.202 | 0.391 | Platelet activating factor antagonist | 0.391 0.005 DBMET01162 | DBMET01162 | |
| 0.06 | 0.225 | 0.138 | Psychostimulant | 0.138 0.128 DBMET01153 | DBMET01153 | |
| 0.098 | 0.264 | 0.67 | Phospholipase C inhibitor | 0.67 0.003 DBMET00657 0.589 0.004 DBMET01151 0.6 0.004 DBMET01158 0.233 0.029 DBMET01159 0.538 0.005 DBMET01152 0.19 0.051 DBMET01160 0.529 0.005 DBMET01153 0.295 0.019 DBMET01154 0.249 0.025 DBMET01155 0.178 0.062 DBMET01156 0.165 0.08 DBMET01157 | DBMET00657 | |
| 0.02 | 0.19 | 0.068 | Carbonic anhydrase V inhibitor | 0.06 0.054 DBMET00657 0.063 0.05 DBMET01151 0.068 0.045 DBMET01152 | DBMET01152 | |
| 0.033 | 0.205 | 0.269 | Phosphodiesterase 3A inhibitor | 0.154 0.015 DBMET00780 0.269 0.005 DBMET01161 | DBMET01161 | |
| 0.074 | 0.246 | 0.121 | Cyclin-dependent kinase 8 inhibitor | 0.121 0.116 DBMET01162 | DBMET01162 | |
| 0.011 | 0.186 | 0.274 | Phosphorylase inhibitor | 0.259 0.004 DBMET00657 0.213 0.005 DBMET01151 0.205 0.005 DBMET01158 0.128 0.009 DBMET01159 0.186 0.005 DBMET01152 0.08 0.017 DBMET01160 0.136 0.008 DBMET01153 0.256 0.004 DBMET01154 0.274 0.004 DBMET01155 0.164 0.006 DBMET01156 0.183 0.005 DBMET01157 | DBMET01155 | |
| 0.047 | 0.228 | 0.427 | Alkylator | 0.192 0.029 DBMET00657 0.124 0.064 DBMET01162 0.145 0.049 DBMET01151 0.226 0.02 DBMET01158 0.124 0.065 DBMET01159 0.236 0.018 DBMET01152 0.152 0.046 DBMET01160 0.427 0.006 DBMET01153 0.199 0.026 DBMET01154 0.172 0.036 DBMET01155 0.235 0.018 DBMET01156 0.205 0.025 DBMET01157 | DBMET01153 | |
| 0.114 | 0.296 | 0.609 | Cholesterol antagonist | 0.304 0.089 DBMET00657 0.241 0.132 DBMET01158 0.609 0.018 DBMET01159 0.532 0.028 DBMET01160 | DBMET01159 | |
| 0.013 | 0.206 | 0.174 | RNA-directed RNA polymerase inhibitor | 0.041 0.018 DBMET00657 0.085 0.006 DBMET01158 0.046 0.014 DBMET01152 0.046 0.014 DBMET01153 0.134 0.004 DBMET01154 0.174 0.004 DBMET01155 0.094 0.005 DBMET01156 0.114 0.005 DBMET01157 | DBMET01155 | |
| 0.026 | 0.222 | 0.173 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.173 0.013 DBMET00657 0.152 0.018 DBMET01151 0.143 0.021 DBMET01158 0.116 0.03 DBMET01152 0.089 0.044 DBMET01153 0.16 0.016 DBMET01154 0.144 0.021 DBMET01155 0.085 0.047 DBMET01156 0.073 0.058 DBMET01157 | DBMET00657 | |
| 0.075 | 0.272 | 0.264 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.264 0.074 DBMET01161 | DBMET01161 | |
| 0.117 | 0.314 | 0.776 | Vasodilator, coronary | 0.573 0.009 DBMET00657 0.201 0.181 DBMET01162 0.477 0.019 DBMET01151 0.624 0.007 DBMET01158 0.705 0.004 DBMET01159 0.35 0.055 DBMET01152 0.776 0.004 DBMET01160 0.407 0.033 DBMET01153 0.479 0.019 DBMET01154 0.508 0.014 DBMET01155 0.286 0.1 DBMET01156 0.31 0.08 DBMET01157 | DBMET01160 | |
| 0.006 | 0.203 | 0.19 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.19 0.002 DBMET00657 0.141 0.002 DBMET01151 0.184 0.002 DBMET01158 0.064 0.004 DBMET01159 0.115 0.002 DBMET01152 0.064 0.004 DBMET01160 0.102 0.003 DBMET01153 0.153 0.002 DBMET01154 0.141 0.002 DBMET01155 0.087 0.003 DBMET01156 0.083 0.003 DBMET01157 | DBMET00657 | |
| 0.115 | 0.319 | 0.813 | DNA directed DNA polymerase inhibitor | 0.545 0.07 DBMET00657 0.469 0.092 DBMET01161 0.648 0.044 DBMET01151 0.481 0.088 DBMET01158 0.345 0.14 DBMET01159 0.393 0.118 DBMET01152 0.284 0.171 DBMET01160 0.637 0.047 DBMET01154 0.704 0.034 DBMET01155 0.762 0.025 DBMET01156 0.813 0.017 DBMET01157 | DBMET01157 | |
| 0.072 | 0.277 | 0.59 | DNA methylase inhibitor | 0.547 0.005 DBMET00657 0.36 0.015 DBMET01151 0.586 0.004 DBMET01158 0.552 0.005 DBMET01159 0.481 0.006 DBMET01152 0.59 0.004 DBMET01160 0.483 0.006 DBMET01153 0.403 0.01 DBMET01154 0.36 0.015 DBMET01155 0.399 0.011 DBMET01156 0.357 0.016 DBMET01157 | DBMET01160 | |
| 0.009 | 0.218 | 0.281 | Phosphodiesterase II inhibitor | 0.111 0.009 DBMET00780 0.281 0.004 DBMET01161 0.056 0.037 DBMET01151 | DBMET01161 | |
| 0.043 | 0.259 | 0.205 | Mucolytic | 0.205 0.012 DBMET00657 0.163 0.025 DBMET01151 0.154 0.03 DBMET01158 0.177 0.02 DBMET01159 0.101 0.076 DBMET01152 0.129 0.046 DBMET01160 0.148 0.033 DBMET01153 0.165 0.024 DBMET01154 0.18 0.019 DBMET01155 0.101 0.075 DBMET01156 0.113 0.061 DBMET01157 | DBMET00657 | |
| 0.037 | 0.259 | 0.114 | HIV-1 integrase (Overall Integration) inhibitor | 0.114 0.043 DBMET01161 | DBMET01161 | |
| 0.06 | 0.313 | 0.487 | DNA methyltransferase I inhibitor | 0.442 0.006 DBMET01159 0.487 0.005 DBMET01160 | DBMET01160 | |
| 0.008 | 0.268 | 0.27 | Phosphodiesterase 2A inhibitor | 0.101 0.009 DBMET00780 0.27 0.004 DBMET01161 0.049 0.035 DBMET01151 | DBMET01161 | |
| 0.05 | 0.31 | 0.231 | Protein kinase stimulant | 0.213 0.037 DBMET00657 0.136 0.078 DBMET01151 0.163 0.06 DBMET01158 0.231 0.032 DBMET01159 0.111 0.103 DBMET01152 0.176 0.052 DBMET01160 | DBMET01159 | |
| 0.005 | 0.266 | 0.226 | HCV NS5B polymerase inhibitor | 0.053 0.009 DBMET00657 0.141 0.004 DBMET01158 0.055 0.009 DBMET01152 0.042 0.013 DBMET01160 0.073 0.007 DBMET01153 0.165 0.004 DBMET01154 0.226 0.004 DBMET01155 0.088 0.005 DBMET01156 0.114 0.004 DBMET01157 | DBMET01155 | |
| 0.097 | 0.366 | 0.67 | Vasodilator, peripheral | 0.49 0.03 DBMET00657 0.283 0.106 DBMET01151 0.627 0.013 DBMET01158 0.572 0.019 DBMET01159 0.407 0.053 DBMET01152 0.67 0.009 DBMET01160 0.407 0.053 DBMET01153 0.629 0.013 DBMET01154 0.659 0.009 DBMET01155 0.449 0.041 DBMET01156 0.491 0.03 DBMET01157 | DBMET01160 | |
| 0.025 | 0.295 | 0.346 | Expectorant | 0.346 0.006 DBMET00657 0.257 0.012 DBMET01151 0.252 0.012 DBMET01158 0.254 0.012 DBMET01159 0.139 0.04 DBMET01152 0.179 0.025 DBMET01160 0.223 0.016 DBMET01153 0.244 0.013 DBMET01154 0.271 0.01 DBMET01155 0.137 0.041 DBMET01156 0.157 0.033 DBMET01157 | DBMET00657 | |
| 0.11 | 0.382 | 0.204 | Histamine release inhibitor | 0.204 0.197 DBMET01162 | DBMET01162 | |
| 0.063 | 0.34 | 0.138 | Hemostatic | 0.138 0.084 DBMET01162 | DBMET01162 | |
| 0.055 | 0.343 | 0.647 | Hexokinase inhibitor | 0.443 0.004 DBMET00657 0.381 0.005 DBMET01151 0.455 0.003 DBMET01158 0.244 0.018 DBMET01159 0.483 0.003 DBMET01152 0.257 0.016 DBMET01160 0.426 0.004 DBMET01153 0.621 0.002 DBMET01154 0.647 0.002 DBMET01155 0.421 0.004 DBMET01156 0.449 0.004 DBMET01157 | DBMET01155 | |
| 0.005 | 0.293 | 0.079 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET01159 0.079 0.004 DBMET01160 | DBMET01160 | |
| 0.087 | 0.38 | 0.551 | Antithrombotic | 0.471 0.033 DBMET00657 0.391 0.052 DBMET01151 0.551 0.022 DBMET01158 0.301 0.087 DBMET01159 0.281 0.102 DBMET01152 0.374 0.056 DBMET01160 0.334 0.07 DBMET01153 0.237 0.137 DBMET01154 0.204 0.172 DBMET01155 | DBMET01158 | |
| 0.092 | 0.389 | 0.43 | Transcription factor inhibitor | 0.43 0.098 DBMET01161 | DBMET01161 | |
| 0.066 | 0.366 | 0.318 | DNA damaging | 0.223 0.098 DBMET00657 0.228 0.094 DBMET01151 0.318 0.051 DBMET01159 0.247 0.082 DBMET01152 0.212 0.106 DBMET01160 0.242 0.085 DBMET01154 0.197 0.118 DBMET01155 0.313 0.052 DBMET01156 0.26 0.075 DBMET01157 | DBMET01159 | |
| 0.042 | 0.344 | 0.179 | Acetylcholine M1 receptor antagonist | 0.132 0.093 DBMET00657 0.173 0.056 DBMET01158 0.121 0.107 DBMET01159 0.16 0.066 DBMET01160 0.163 0.064 DBMET01154 0.179 0.052 DBMET01155 0.136 0.088 DBMET01156 0.151 0.074 DBMET01157 | DBMET01155 | |
| 0.006 | 0.311 | 0.058 | Sodium/glucose cotransporter inhibitor | 0.027 0.016 DBMET01159 0.058 0.004 DBMET01160 | DBMET01160 | |
| 0.073 | 0.381 | 0.391 | DNA polymerase beta inhibitor | 0.391 0.123 DBMET01161 | DBMET01161 | |
| 0.03 | 0.344 | 0.134 | AMP-activated protein kinase stimulant | 0.09 0.085 DBMET01158 0.134 0.038 DBMET01160 | DBMET01160 | |
| 0.071 | 0.386 | 0.241 | Transcription factor NF kappa B inhibitor | 0.192 0.177 DBMET01159 0.241 0.134 DBMET01160 | DBMET01160 | |
| 0.004 | 0.321 | 0.059 | Calcitonin gene-related peptide 1 receptor antagonist | 0.017 0.012 DBMET00780 0.059 0.005 DBMET01161 | DBMET01161 | |
| 0.005 | 0.323 | 0.38 | Purinergic P2Y12 antagonist | 0.208 0.004 DBMET00657 0.044 0.008 DBMET00780 0.35 0.003 DBMET01161 0.38 0.003 DBMET01151 0.233 0.004 DBMET01158 0.054 0.006 DBMET01159 0.086 0.004 DBMET01152 0.065 0.005 DBMET01160 0.085 0.004 DBMET01153 0.201 0.004 DBMET01154 0.254 0.003 DBMET01155 0.1 0.004 DBMET01156 0.146 0.004 DBMET01157 | DBMET01151 | |
| 0.04 | 0.372 | 0.1 | Phosphodiesterase 6D inhibitor | 0.1 0.052 DBMET01160 | DBMET01160 | |
| 0.06 | 0.403 | 0.214 | Lipoxygenase inhibitor | 0.214 0.126 DBMET01161 | DBMET01161 | |
| 0.013 | 0.366 | 0.315 | Nicotinic acid receptor 1 agonist | 0.308 0.003 DBMET01152 0.315 0.003 DBMET01153 0.27 0.003 DBMET01154 0.257 0.003 DBMET01155 0.258 0.003 DBMET01156 0.246 0.003 DBMET01157 | DBMET01153 | |
| 0.001 | 0.362 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.006 DBMET01152 | DBMET01152 | |
| 0.031 | 0.396 | 0.135 | MAP kinase 13 inhibitor | 0.135 0.044 DBMET01162 | DBMET01162 | |
| 0.1 | 0.479 | 0.431 | MAP kinase 1 inhibitor | 0.431 0.088 DBMET01161 | DBMET01161 | |
| 0.008 | 0.389 | 0.077 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.077 0.026 DBMET00657 0.055 0.045 DBMET01151 0.061 0.039 DBMET01158 | DBMET00657 | |
| 0.025 | 0.479 | 0.577 | Dual specificity phosphatase 3 inhibitor | 0.147 0.099 DBMET00657 0.577 0.005 DBMET01161 0.127 0.119 DBMET01151 0.425 0.011 DBMET01159 | DBMET01161 | |
| 0.062 | 0.518 | 0.648 | Immunomodulator | 0.519 0.02 DBMET00657 0.272 0.099 DBMET00780 0.533 0.019 DBMET01151 0.641 0.008 DBMET01158 0.503 0.023 DBMET01159 0.549 0.017 DBMET01152 0.648 0.008 DBMET01160 0.467 0.028 DBMET01153 0.581 0.013 DBMET01154 0.562 0.015 DBMET01155 0.528 0.019 DBMET01156 0.506 0.022 DBMET01157 | DBMET01160 | |
| 0.023 | 0.521 | 0.068 | Gonadotropin-releasing hormone receptor agonist | 0.068 0.028 DBMET01162 | DBMET01162 | |
| 0.049 | 0.573 | 0.226 | Toll-Like receptor 7 agonist | 0.226 0.171 DBMET00780 | DBMET00780 | |
| 0.045 | 0.586 | 0.218 | Toll-Like receptor agonist | 0.218 0.181 DBMET00780 | DBMET00780 | |
| 0.023 | 0.566 | 0.435 | Platelet aggregation inhibitor | 0.435 0.015 DBMET01162 0.156 0.122 DBMET01153 | DBMET01162 | |
| 0.018 | 0.565 | 0.269 | Beta lactamase inhibitor | 0.269 0.148 DBMET01161 | DBMET01161 | |
| 0.031 | 0.579 | 0.463 | Cardiotonic | 0.19 0.128 DBMET00657 0.366 0.035 DBMET01158 0.263 0.074 DBMET01159 0.463 0.019 DBMET01160 | DBMET01160 | |
| 0.019 | 0.581 | 0.505 | Dual specificity phosphatase inhibitor | 0.505 0.006 DBMET01161 0.349 0.021 DBMET01159 | DBMET01161 | |
| 0.003 | 0.586 | 0.178 | Purinergic P2Y1 antagonist | 0.173 0.002 DBMET00657 0.141 0.002 DBMET01151 0.178 0.002 DBMET01158 0.024 0.006 DBMET01159 0.087 0.003 DBMET01152 0.027 0.005 DBMET01160 0.086 0.003 DBMET01153 0.096 0.003 DBMET01154 0.107 0.003 DBMET01155 0.101 0.003 DBMET01156 0.114 0.002 DBMET01157 | DBMET01158 | |
| 0.019 | 0.618 | 0.384 | Streptokinase A inhibitor | 0.384 0.051 DBMET01161 | DBMET01161 | |
| 0.005 | 0.623 | 0.09 | Selectin antagonist | 0.09 0.032 DBMET01159 0.087 0.033 DBMET01160 | DBMET01159 | |
| 0.02 | 0.639 | 0.23 | Insulin secretagoues | 0.145 0.079 DBMET00657 0.23 0.024 DBMET01158 0.13 0.096 DBMET01152 0.211 0.03 DBMET01160 0.119 0.113 DBMET01153 0.184 0.045 DBMET01154 0.196 0.038 DBMET01155 0.129 0.098 DBMET01157 | DBMET01158 | |
| 0.014 | 0.64 | 0.372 | Alpha-glucosidase inhibitor | 0.372 0.126 DBMET01161 | DBMET01161 | |
| 0.045 | 0.706 | 0.261 | Antiinflammatory | 0.261 0.255 DBMET01160 | DBMET01160 | |
| 0.008 | 0.683 | 0.075 | Acetyl-CoA transferase 2 inhibitor | 0.075 0.014 DBMET01162 0.058 0.037 DBMET01160 | DBMET01162 | |
| 0.005 | 0.693 | 0.318 | Purinergic P2 antagonist | 0.225 0.005 DBMET00657 0.058 0.05 DBMET01161 0.318 0.004 DBMET01151 0.275 0.005 DBMET01158 0.18 0.008 DBMET01152 0.153 0.01 DBMET01153 0.269 0.005 DBMET01154 0.303 0.005 DBMET01155 0.238 0.005 DBMET01156 0.272 0.005 DBMET01157 | DBMET01151 | |
| 0.008 | 0.71 | 0.297 | Purinergic P2X2 antagonist | 0.243 0.003 DBMET00657 0.228 0.004 DBMET01151 0.246 0.003 DBMET01158 0.132 0.016 DBMET01159 0.241 0.003 DBMET01152 0.144 0.013 DBMET01160 0.24 0.003 DBMET01153 0.28 0.002 DBMET01154 0.297 0.002 DBMET01155 0.259 0.003 DBMET01156 0.276 0.002 DBMET01157 | DBMET01155 | |
| 0.012 | 0.749 | 0.36 | Vasodilator | 0.349 0.033 DBMET00657 0.28 0.055 DBMET01151 0.36 0.031 DBMET01158 0.328 0.039 DBMET01159 0.197 0.107 DBMET01152 0.342 0.035 DBMET01160 0.225 0.086 DBMET01153 0.248 0.07 DBMET01154 0.267 0.061 DBMET01155 0.166 0.135 DBMET01156 0.187 0.116 DBMET01157 | DBMET01158 | |
| 0.004 | 0.743 | 0.047 | Poly(ADP-ribose) polymerase inhibitor | 0.047 0.027 DBMET01162 | DBMET01162 | |
| 0.005 | 0.749 | 0.197 | Topoisomerase I inhibitor | 0.189 0.029 DBMET01159 0.197 0.027 DBMET01160 | DBMET01160 | |
| 0.01 | 0.784 | 0.181 | Tumour necrosis factor alpha release inhibitor | 0.181 0.125 DBMET01158 0.178 0.128 DBMET01160 | DBMET01158 | |
| 0.011 | 0.8 | 0.11 | Antiviral (Hepatitis D) | 0.047 0.045 DBMET01158 0.096 0.005 DBMET01154 0.11 0.004 DBMET01155 0.094 0.005 DBMET01156 0.108 0.004 DBMET01157 | DBMET01155 | |
| 0.005 | 0.808 | 0.469 | Cyclophilin A inhibitor | 0.469 0.001 DBMET01162 0.046 0.008 DBMET01153 | DBMET01162 | |
| 0.018 | 0.846 | 0.106 | Hematopoietic | 0.09 0.05 DBMET00657 0.1 0.036 DBMET01151 0.09 0.049 DBMET01158 0.106 0.03 DBMET01152 0.105 0.031 DBMET01153 0.085 0.059 DBMET01154 0.082 0.066 DBMET01155 0.084 0.063 DBMET01156 0.081 0.071 DBMET01157 | DBMET01152 | |
| 0.013 | 0.86 | 0.378 | Apoptosis agonist | 0.27 0.195 DBMET00657 0.378 0.124 DBMET01158 0.238 0.228 DBMET01159 0.294 0.177 DBMET01152 0.363 0.132 DBMET01160 | DBMET01158 | |
| 0.009 | 0.859 | 0.223 | Angiogenesis stimulant | 0.167 0.112 DBMET00657 0.141 0.129 DBMET01151 0.166 0.113 DBMET01158 0.223 0.083 DBMET01159 0.157 0.118 DBMET01152 0.221 0.084 DBMET01160 0.158 0.117 DBMET01153 | DBMET01159 | |
| 0.016 | 0.884 | 0.219 | Hepatoprotectant | 0.162 0.098 DBMET00657 0.139 0.122 DBMET01151 0.138 0.123 DBMET01158 0.219 0.055 DBMET01159 0.194 0.069 DBMET01160 | DBMET01159 | |
| 0.005 | 0.885 | 0.187 | Antioxidant | 0.187 0.126 DBMET01159 | DBMET01159 | |
| 0.005 | 0.887 | 0.497 | Thioredoxin glutathione reductase inhibitor | 0.497 0.029 DBMET01161 | DBMET01161 | |
| 0.021 | 0.914 | 0.208 | Folate antagonist | 0.208 0.009 DBMET01152 0.208 0.009 DBMET01153 0.169 0.016 DBMET01154 0.163 0.018 DBMET01155 0.158 0.02 DBMET01156 0.152 0.022 DBMET01157 | DBMET01153 | |
| 0.005 | 0.906 | 0.056 | Antibiotic Aminoglycoside-like | 0.042 0.019 DBMET00657 0.04 0.021 DBMET01151 0.045 0.017 DBMET01158 0.053 0.011 DBMET01159 0.042 0.019 DBMET01152 0.056 0.01 DBMET01160 0.043 0.018 DBMET01153 0.039 0.022 DBMET01154 0.039 0.022 DBMET01155 0.041 0.02 DBMET01156 0.04 0.021 DBMET01157 | DBMET01160 | |
| 0.002 | 0.921 | 0.301 | Purinergic P2T antagonist | 0.174 0.004 DBMET00657 0.161 0.004 DBMET01151 0.189 0.004 DBMET01158 0.08 0.006 DBMET01159 0.093 0.005 DBMET01152 0.086 0.005 DBMET01160 0.096 0.005 DBMET01153 0.226 0.004 DBMET01154 0.301 0.003 DBMET01155 0.13 0.004 DBMET01156 0.163 0.004 DBMET01157 | DBMET01155 | |
| 0.041 | 0.963 | 0.329 | Peptidyltransferase inhibitor | 0.228 0.068 DBMET00657 0.226 0.07 DBMET01151 0.27 0.038 DBMET01158 0.295 0.027 DBMET01159 0.241 0.057 DBMET01152 0.329 0.016 DBMET01160 0.271 0.037 DBMET01153 0.221 0.075 DBMET01154 0.215 0.081 DBMET01155 0.255 0.047 DBMET01156 0.249 0.052 DBMET01157 | DBMET01160 | |
| 0.004 | 0.928 | 0.088 | Protein 50S ribosomal subunit inhibitor | 0.08 0.02 DBMET00657 0.081 0.019 DBMET01151 0.083 0.018 DBMET01158 0.084 0.018 DBMET01159 0.063 0.028 DBMET01152 0.088 0.016 DBMET01160 0.069 0.024 DBMET01153 0.057 0.033 DBMET01154 0.055 0.035 DBMET01155 | DBMET01160 | |
| 0.024 | 0.968 | 0.126 | Sphingosine 1-phosphate receptor 2 agonist | 0.122 0.052 DBMET00657 0.111 0.073 DBMET01151 0.123 0.051 DBMET01158 0.126 0.047 DBMET01152 0.113 0.068 DBMET01153 | DBMET01152 | |
| 0.004 | 0.948 | 0.233 | Platelet antagonist | 0.182 0.115 DBMET00657 0.233 0.08 DBMET01158 0.156 0.138 DBMET01160 0.174 0.122 DBMET01154 0.189 0.11 DBMET01155 | DBMET01158 | |
| 0 | 0.954 | 0.016 | Mannitol 2-dehydrogenase inhibitor | 0.016 0.003 DBMET00657 0.014 0.003 DBMET01151 0.015 0.003 DBMET01158 0.013 0.003 DBMET01152 0.012 0.004 DBMET01153 | DBMET00657 | |
| 0.005 | 0.978 | 0.14 | Bone formation stimulant | 0.123 0.083 DBMET00657 0.14 0.068 DBMET01158 | DBMET01158 | |
| 0.007 | 0.983 | 0.081 | T cell inhibitor | 0.081 0.063 DBMET01159 0.079 0.069 DBMET01160 | DBMET01159 | |
| 0.004 | 0.981 | 0.135 | Interleukin antagonist | 0.135 0.13 DBMET01161 | DBMET01161 | |
| 0.002 | 0.982 | 0.04 | Purinergic P2X3 antagonist | 0.032 0.028 DBMET01158 0.033 0.026 DBMET01154 0.04 0.017 DBMET01155 | DBMET01155 | |
| 0.007 | 0.988 | 0.141 | Interleukin 5 antagonist | 0.128 0.019 DBMET00780 0.141 0.014 DBMET01161 | DBMET01161 | |
| 0.009 | 0.992 | 0.167 | Heme oxygenase stimulant | 0.085 0.012 DBMET00780 0.167 0.002 DBMET01161 0.087 0.011 DBMET01151 | DBMET01161 | |
| 0.01 | 0.993 | 0.151 | Transcription factor NF kappa B stimulant | 0.136 0.019 DBMET00657 0.126 0.023 DBMET01151 0.135 0.019 DBMET01158 0.125 0.023 DBMET01159 0.117 0.027 DBMET01152 0.124 0.024 DBMET01160 0.126 0.022 DBMET01153 0.151 0.016 DBMET01154 0.145 0.017 DBMET01155 0.122 0.024 DBMET01156 0.118 0.026 DBMET01157 | DBMET01154 | |
| 0.005 | 0.988 | 0.258 | Apoptosis antagonist | 0.194 0.188 DBMET01158 0.244 0.133 DBMET01159 0.197 0.183 DBMET01152 0.258 0.119 DBMET01160 | DBMET01160 | |
| 0.008 | 0.992 | 0.214 | Caspase 3 stimulant | 0.214 0.15 DBMET01160 | DBMET01160 | |
| 0.002 | 0.986 | 0.037 | Elastase 2 inhibitor | 0.037 0.007 DBMET01162 | DBMET01162 | |
| 0.002 | 0.986 | 0.037 | Elastase 2A inhibitor | 0.037 0.007 DBMET01162 | DBMET01162 | |
| 0.002 | 0.987 | 0.034 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.026 DBMET00657 0.033 0.029 DBMET01151 0.032 0.031 DBMET01158 0.032 0.031 DBMET01152 | DBMET00657 | |
| 0.004 | 0.989 | 0.233 | Cyclophilin D inhibitor | 0.233 0.232 DBMET01160 | DBMET01160 | |
| 0.003 | 0.991 | 0.037 | Toll-Like receptor 4 agonist | 0.037 0.006 DBMET00657 0.035 0.007 DBMET01151 0.037 0.006 DBMET01158 0.035 0.007 DBMET01152 0.035 0.007 DBMET01153 0.03 0.012 DBMET01154 0.029 0.013 DBMET01155 0.028 0.014 DBMET01156 0.028 0.015 DBMET01157 | DBMET01158 | |
| 0.004 | 0.993 | 0.24 | Hypoglycemic | 0.24 0.083 DBMET01160 | DBMET01160 | |
| 0.004 | 0.994 | 0.243 | Platelet adhesion inhibitor | 0.176 0.085 DBMET00657 0.156 0.099 DBMET01151 0.235 0.055 DBMET01158 0.173 0.086 DBMET01159 0.243 0.052 DBMET01160 | DBMET01160 | |
| 0.005 | 0.996 | 0.357 | Interleukin 4 antagonist | 0.257 0.012 DBMET00780 0.357 0.005 DBMET01161 | DBMET01161 | |
| 0.004 | 0.996 | 0.099 | Toll-Like receptor 4 antagonist | 0.097 0.074 DBMET00657 0.092 0.084 DBMET01158 0.099 0.071 DBMET01152 | DBMET01152 | |
| 0.003 | 0.996 | 0.148 | Interleukin 6 antagonist | 0.148 0.093 DBMET01158 0.147 0.093 DBMET01160 | DBMET01158 | |
| 0.002 | 0.995 | 0.102 | HIV-1 integrase (3'-Processing) inhibitor | 0.097 0.027 DBMET00657 0.102 0.025 DBMET01151 | DBMET01151 | |
| 0.003 | 0.996 | 0.108 | Thioredoxin inhibitor | 0.093 0.058 DBMET01159 0.098 0.05 DBMET01160 0.108 0.04 DBMET01156 0.102 0.046 DBMET01157 | DBMET01156 | |
| 0.002 | 0.995 | 0.099 | HIV-1 integrase (Strand Transfer) inhibitor | 0.096 0.024 DBMET00657 0.099 0.023 DBMET01151 | DBMET01151 | |
| 0.004 | 0.997 | 0.069 | Adenine nucleotide translocase inhibitor | 0.066 0.02 DBMET00657 0.064 0.022 DBMET01151 0.069 0.016 DBMET01158 0.058 0.032 DBMET01159 0.062 0.025 DBMET01152 0.062 0.025 DBMET01160 0.063 0.023 DBMET01153 0.057 0.034 DBMET01154 0.056 0.038 DBMET01155 | DBMET01158 | |
| 0.001 | 0.996 | 0.06 | Sphingosine 1-phosphate receptor 3 agonist | 0.058 0.013 DBMET00657 0.047 0.017 DBMET01151 0.06 0.012 DBMET01158 0.047 0.018 DBMET01152 0.045 0.019 DBMET01153 | DBMET01158 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |